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ABSTRACT 
PATIENT WEB PORTAL USE AMONG WOMEN WITH GESTATIONAL DIABETES 
by 
Megan M. Anderson 
University of Wisconsin-Milwaukee, 2017 
Under the Supervision of Professor Dr. Jennifer Doering 
 
Background: The prevalence of gestational diabetes mellitus (GDM) continues to 
increase.  Research suggests that adverse maternal and newborn outcomes increase in relation to 
the mother’s elevated blood glucose levels. Diabetes researchers discuss that utilizing 
information technology for self-management, particularly Internet-based modes of delivery, may 
result in individual improvements in diabetes outcomes. Scant research exists on the use of 
Internet-based tools such as patient web portals (PWPs) for GDM self-management and 
outcomes. 
Purpose: The purpose of this study was to examine PWP use in women with GDM. 
Specific aims of this study included: 1) compare the characteristics of nonusers and users of a 
patient web portal (PWP) for self-management including relationships between characteristics 
and PWP use, 2) in users of the PWP, describe the frequency and patterns of  PWP use, and 3) 
compare glycemic control between PWP users and nonusers.   
Methods: A retrospective study was conducted using electronic health record (EHR) 
review of PWP users (n=91) and nonusers (n=67) who sought care in a diabetes and pregnancy 
clinic for GDM management.  
Results: PWP users were more likely to be employed fulltime than nonusers (p= .011). 
There were no statistically significant differences between users and nonusers for the other 
patient characteristics. Most users accessed the PWP each month in the third trimester but the 
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number of days accessed varied greatly. The AVS [24.31 (SD 25.05)] and appointment 
reminders [15.44 (SD 17.00)] were accessed most frequently. Glycemic control did not differ 
significantly between users and nonusers (F (1.520, 191.474) = 184.428, p=.559).  
Discussion: This research provides insight into the patient characteristics of users and 
nonusers of a PWP for a non-chronic condition (GDM) and outlines the features of the PWP 
used.  Patient web portals should be further stringently evaluated for their usability in this 
population of patients including facilitators and barriers to its use as well as dosage of utilization. 
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Chapter 1 
Background/Problem Identification 
The prevalence of gestational diabetes mellitus (GDM) in the United States is as high as 
9.2% according to a recent analysis performed by the Center for Disease Control and Prevention, 
and it has more than doubled since 1990 (DeSisto, Kim, & Sharma, 2014; Gethun, Nath, Ananth, 
Chavez, & Smulian, 2008). Research suggests that GDM may be associated with multiple 
pregnancies, obesity, sedentary lifestyle, insufficient sleep, and high maternal age at time of 
pregnancy (Kim et al., 2010; Qiu, Enquobahrie, Frederick, Abetew, & Williams, 2010). 
The 2010 International Association of Diabetes and Pregnancy Study Group’s (IADPSG) 
new screening guidelines revised the criteria for diagnosing GDM, to using a single fasting 75 
gram 2-hour oral glucose tolerance test (OGTT). GDM rates are rising while the debate 
continues on whether evidence supports the IADPSG’s new screening guidelines versus the 
traditional two step screen (e.g. a non-fasted one-hour, 50-gram test followed by a 3- hour, 100 
gram OGTT).  The new guidelines have the potential for the identification of women with GDM 
to nearly double (Metzger, 2010).  
Gestational diabetes mellitus is unique in the sense that it is a condition that can 
adversely affect both the mother and the unborn baby. Newborns of mothers with poorly 
controlled GDM have higher rates of macrosomia, birth injuries such as fractures or nerve 
damage, and respiratory complications (Alwan, Tuffnell, & West, 2009). Infants born to mothers 
with GDM are also at increased risk for obesity and type 2 diabetes during childhood or 
adolescence (Ferrara et al., 2004).  Mothers with poorly controlled gestational diabetes mellitus 
are at increased risk for cesarean delivery, preterm delivery, and preeclampsia (Bellamy, Casas, 
Hingorani, & Williams, 2009; Langer, Yogev, Xanakis, & Brustman, 2005). Women with GDM 
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are 2 to 3 times more likely to develop GDM with subsequent pregnancies and have a 7 times 
greater risk of developing type 2 diabetes later in life (Bellamy et al., 2009).  Furthermore, there 
is a 2 to 3 times higher morbidity rate for women and their newborns when GDM is not 
adequately managed (Langer et al., 2005).  
Conversely, when GDM is diagnosed in a timely manner and well managed, the 
maternal, fetal, and newborn health risks are reduced (Carolan, Gill, & Steele, 2012). Gestational 
diabetes is typically diagnosed between 24 and 28 weeks of pregnancy providing a short time 
(roughly 3 months) for these women to learn about their diagnosis and participate in health 
management of their diabetes to optimize outcomes and reduce adverse effects.  GDM 
management plans typically consist of goal-setting for dietary modifications, exercise, and blood 
glucose monitoring (Hoffman, Nolan, Wilson, Oats, & Simmons, 1998).  Results from the 
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study found that adverse maternal, 
fetal, and neonatal outcomes rise in relation to the mother’s elevated glucose levels (Metzger, 
Lowe, Dyer,Trimble, Chaovarindr, & Coustan, 2008).  Therefore, the goal of treatment is to 
maintain blood glucose levels within recommended ranges, which is accomplished through 
rigorous self-management of blood glucose testing, exercise, and dietary adjustments (Carolan, 
2015; Hoffman et al., 1998). Women who are not able to maintain blood glucose levels within 
the target ranges with diet therapy and exercise may need insulin to control their GDM.  The goal 
of insulin therapy in addition to diet therapy and exercise is to achieve glucose profiles similar to 
those of non-diabetic pregnant women (Moore, 2016). 
 A key component to GDM treatment and self-management is education.  Education is 
time intensive for the healthcare team.  Research suggests that health care information can be 
effectively communicated through the use of information technology by providers and nurses 
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thus;  providing an additional mode of nurse/patient communication for care delivery (Jackson, 
Boren, Brancati, Batts-Turner, & Gary, 2006).  
People who actively seek to learn about their health and attempt to manage their health 
are more likely to participate in healthy behaviors, engage in self-management of their health, 
have higher satisfaction, and achieve better health outcomes (Hibbard & Greene, 2013; 
Ricciardi, Mostashari, & Murphy et al., 2013).  Patient web portals (PWP) are a part of 
electronic health records (EHR) that  have shown to be a successful tool among a wide range of 
patients including women, those with chronic conditions, and potentially those with lower 
income (Ancker et al., 2011; Emont, 2011; Kruse, Bolton & Freriks, 2015; Lam et al., 2013; 
McMahon et al., 2005).  The success of patient portals have gained the attention of the United 
States (US) Centers for Medicare and Medicaid Services (CMS) and are now part of the 
meaningful use measures for their EHR incentive programs for eligible professionals and 
hospitals (CMS, 2016).   
Diabetes research suggests that utilizing information technology for care and self-
management, particularly Internet-based modes of delivery results in individual improvements in 
diabetes clinical outcomes and quality of care (Kwon et al., 2004; McMahon et al., 2005; Meigs 
et al., 2003; Quinn et al., 2008).  Specifically, studies of individuals with type 1 and type 2 
diabetes who use a patient web portal (PWP) experience lower HgbA1c levels and lower blood 
pressure over time than individuals not using a PWP (Fonda, McMahon, Gomes, Hickson, & 
Conlin, 2009; McMahon et al., 2005; Quinn et al., 2008). While PWPs have been evaluated in 
persons with type 1 and type 2 diabetes their usefulness in patients with GDM has not. 
Studies related to GDM note the desire for improved access to effective education and 
care delivery using a participatory model which includes chat rooms, message boards, and other 
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forms of technology (Nolan, McCrone, & Chertok, 2011).  Furthermore, a study by Kaptein et al. 
(2014) points to the need to provide education and care to this population that minimizes travel 
and time commitments. Patient web portals potentially offer an effective care delivery and self-
management tool that may minimize travel and time. Only one study exists in the literature on 
the use of a PWP for GDM self-management (Carolan, Steele, & Krenzin, 2015).   
Identifying the differences between PWP users and nonusers could provide information 
to target and support nonusers in becoming more active in their diabetes self-management. 
Variations exist within the literature on definitions and categories of users and nonusers of PWPs 
(Ronda, Dijkhorst-Oei, & Rutten, 2015; Sarkar et al., 2011; Weingart, Rind, Tofias, & Sands, 
2006; Yamin et al., 2011).  For the purposes of this study nonusers will apply to subjects who log 
in only once. Users will be classified as either short-term users or persistent users. Short-term 
users are women who log in only during the first month after enrollment only. Persistent users 
are those who login throughout the third trimester.  
 In addition, the results of this study could assist organizations with future updates and 
revisions to PWPs for GDM management.  Effective GDM self-management interventions have 
the potential to reduce adverse outcomes for mothers and babies during pregnancy and later in 
life.  Patient web portals also have the potential to address some of the barriers to GDM self-
management as identified by patients related to travel and time and may decrease health care 
costs. Keeping in line with Roger’s Diffusion of Innovation Theory, this research can contribute 
to the body of knowledge related to early adopters of PWP use and the laggards or non-adopters 
so future modifications can be tailored to meet the needs across all levels of adopters (Sahin, 
2006).  
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Purpose 
The purpose of this study was to examine patient web portal (PWP) use in women with 
gestational diabetes mellitus (GDM).   
Specific Aims 
In women with gestational diabetes: 
Aim 1: Compare the characteristics of nonusers and users of a patient web portal (PWP) for self-
management including relationships between characteristics and PWP use/nonuse. 
Aim 2: In users of the PWP, describe the frequency and patterns of PWP use.  
Aim 3. Compare glycemic control between PWP users and nonusers. 
Theoretical Framework 
 The Individual and Family Self-Management Theory (IFSMT) by Ryan and Sawin 
(2009) was the theoretical foundation of this study.  This theory was chosen for several reasons. 
The IFSMT suggests applicability beyond chronic conditions and has been utilized in studies on 
health promotion and prevention including osteoporosis prevention and postpartum fatigue 
(Doering, 2013; Ryan & Sawin, 2009).  Furthermore, the theory is comprehensive and maps well 
to the variables being studied.  The major components of the IFSMT focus on risk and protective 
factors, which align with the patient characteristics of this study as well as the condition 
complexity.  Likewise, the patient web portal (PWP) applies to the process domain of the 
IFSMT. Finally, glycemic control relates to the IFSMT as an outcome. 
It should be noted that the intent of this study was not to examine the process of self-
management rather to determine the patient characteristics (context) of users and nonusers of a 
PWP for gestational diabetes mellitus (GDM) self-management.  The study explored the 
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frequency and patterns of PWP use over the last trimester of pregnancy.  Specific features of the 
PWP that were measured included flowsheets, lab results, medication refills, secure messaging, 
appointment reminders, and patient instructions all of which relate to the process domain of the 
IFSMT.  Finally, the relationship between PWP use and glycemic control, an outcome, in the 
IFSMT, was measured by percentage of blood glucose levels within target range. Figure 1 
outlines the relationship of this study’s variables to the IFSMT. The model in figure 2, which 
guides the study, includes three major dimensions based on the IFSMT model: Content, Process 
and Outcome.  The variables for this study are organized into one of these three categories.   
Context 
According to the IFSMT (Ryan & Sawin, 2009), the context dimension is defined by risk 
and protective factors including condition-specific factors, physical and social environments, and 
individual and family characteristics.  Condition specific factors are structural, functional, or 
physiological characteristics of the condition or treatment and may include complexity of the 
condition.   
Condition specific factors. Condition specific factors in this study were type of GDM 
(diet controlled or insulin), number of pregnancies with GDM, and BMI.  The physical and 
social environment of the context dimension pertains to the physical and social factors that are 
barriers or facilitators to self-management.  Examples of these factors, as outlined by Ryan and 
Sawin (2009), are access to healthcare, culture, and social capital.  Race, ethnicity, marital status, 
employment, and health insurance were patient characteristics examined in this study that fit into 
the physical and social environment construct. The third and final construct of the context 
dimension are the individual and family characteristics.  These are characteristics of the 
individual or family that could promote or inhibit self- management.  Age is included as a 
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variable in this construct.  Table 1 provides a visual of the variables for the study as they relate to 
the constructs and concepts of the IFSMT. 
Process 
The process domain of the IFSMT encompasses the Integrated Theory of Health 
Behavior Change (ITHBC) model and includes knowledge and beliefs, self-regulation skills and 
abilities, and social facilitation (Ryan & Sawin, 2009). First, knowledge consists of factual 
information related to the specific condition and beliefs refer to the personal perceptions about 
the health condition or health behavior.  Secondly, self-regulation is used to alter health behavior 
and includes goal setting, self-monitoring, decision-making, and management of responses 
associated with health behavior change.  Self-regulation is defined as a process people use to 
incorporate a behavior change into their routine. Finally, social facilitation incorporates social 
support, social influence, and collaboration between individuals, health care providers, and 
families (Ryan and Sawin).   
Application of IFSMT to this study. The patient web portal (PWP) in this study 
functions as the intervention, which may or may not influence the process dimension of the 
IFSMT. A PWP provides access to parts of the electronic health record (EHR). It is hypothesized 
that users of the patient portal will experience better glycemic control as measured by a higher 
percentage of blood glucose numbers within target range.  Patient portals vary in their 
functionality but according to the National Learning Consortium and HealthIT.gov (2013), 
patient portals typically allow patients to check lab and test results, review health information, 
communicate to their health care team, access educational resources, request medication refills, 
issue appointment reminders, and handle other tasks such as entering in and monitoring blood 
sugar values.   
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The PWP in this study has the features listed above and are incorporated into Table 2 to 
outline its relationship to the process concepts of the IFSMT.  For example, self-monitoring was 
measured through frequency of entering and reviewing blood sugars in the blood sugar log, 
reviewing lab results, and engaging in behavior to request medication refills using the PWP.  The 
medication refills could also apply to decision-making.  Social support was measured through the 
frequency of email communication to the healthcare team using the PWP.  Finally, knowledge 
was measured through review of educational information on the PWP from the after visit 
summaries and flow sheets.  
Outcomes 
 The IFSMT (Ryan & Sawin, 2009) defined outcomes as proximal or distal.  The proximal 
outcome is engagement in self-management behaviors to manage a condition or symptoms and 
pharmacological therapies.  Distal outcomes include health status as defined by prevention, 
attenuation, stabilization, or worsening of a condition; quality of life; and direct and indirect 
costs.   
Outcomes of this study. Proximal outcomes were not measured in this study because of 
the retrospective nature of the study and the inability to measure the full conceptual definition of 
PWP use which includes frequency and time spent in each feature of the PWP. Future research 
could incorporate the full conceptual definition of PWP use and potentially measure it as a self-
management behavior. The distal outcome variable in this study was glycemic control as 
measured by percentage of blood glucose levels within target range.  This is an indicator of 
health status and determines stabilization of worsening of GDM.  
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Conceptual and Operational Definitions 
 This section provides conceptual and operational definitions relevant to this study.   
Gestational Diabetes. Gestational diabetes (GDM) was defined as glucose or 
carbohydrate intolerance with onset or first diagnosis during the pregnancy (Carolan, Steele, & 
Margetts, 2010; Hui, Sevenhuysen, Harvey, & Salamon, 2014 ).  Women who develop type 1 
diabetes or who have undiagnosed type 2 diabetes that is verified during pregnancy are 
diagnosed with GDM (Nolan et al., 2011).  It is a transient condition that can have serious 
adverse outcomes for mother and baby (Carolan, Steele, & Margetts, 2010). 
Glycemic control. Target blood glucose levels were measured using the percentage of 
blood sugars reported each month within target range per subject.  Target blood glucose levels 
were identified as less than 125 mg/dL for fasting and two hours post-meal (Moore, 2016). 
 Self-management. Self-management is a dynamic phenomenon consisting of context, 
process, and outcomes (Ryan & Sawin, 2009).  Individual and family self-management includes 
the integration of health-related behaviors into a person and/or family’s daily functioning (Ryan 
& Sawin, 2009). 
Electronic Health Record (EHR). According to the National Alliance for Health 
Information Technology (2008) an EHR is an electronic health-related record on an individual 
that meets nationally established interoperability standards and that can be created and managed 
by staff across more than one healthcare organization.  The Healthcare Information and 
Management Systems Society (HIMSS) adds that the EHR is a longitudinal electronic record of 
patient’s health information gathered from sources such as office visits, hospital encounters, 
problem lists, medications, and allergies (HIMSS, 2016).  Most EHRs today include patient 
demographics, financial information, lab and diagnostic results, medications, allergies, problem 
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lists, and clinical documentation (Seckman, 2014). Standards for EHRs were first developed in 
2003 by the EHR Collaborative, under the direction of the U.S. Department of Health and 
Human Services (Seckman, 2014) 
Patient web portal (PWP). An electronic personal health record that directly links to an 
EHR is referred to as a patient web portal (Irizarry, DeVito-Dabbs, & Curran, 2015).  The 
operational definition of the PWP was the study organization’s PWP, Epic MyChart.  MyChart 
acts as the point of entry for all features of the PWP at this health care institution. More 
information on the functionality of MyChart is discussed in Chapter 3.  
Patient web portal use. Patient web portal (PWP) use is not clearly defined in the 
literature. Some define it as the amount of time spent in the PWP and the frequency of use or 
log-in (Fonda et al., 2009). Others take a more comprehensive approach capturing frequency, 
consistency, and duration in their definition of PWP use (Jones, Weiner, Shah, & Stewart, 2015). 
The operational definition for pattern of use in this study included frequency and consistency. 
Duration was unable to be captured in this study and is noted as a limitation. Frequency was the 
utilization of PWP features from first appointment in the diabetes in pregnancy clinic to the time 
of delivery.  It includes the PWP features accessed and the number of hits on each feature over 
the study period. Consistency captures the distribution of PWP use over the study period and was 
measured in hit days and hit months. Hit day was any day that the patient accessed the PWP in 
the third trimester regardless of the number of times accessed that day or features accessed. Hit 
month captured any individual month where the patient accessed any feature of the PWP at least 
once.       
 Patient portal users and nonusers. For the purposes of this study nonusers applied to 
subjects who logged in only once.  Short-term users were women who stopped logging in after 
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the first month of enrollment.  Persistent users were users that logged in throughout the third 
trimester.   
Assumptions 
1) PWP use reflects an aspect of self-management (Ryan & Sawin, 2009). 
2) PWP users have access to a computer and the technical skills to adequately navigate 
the PWP. 
3) PWP users enter accurate information into the PWP and interpret PWP information 
accurately. 
Significance 
Practice 
Nurses represent one of the largest groups of EHR users therefore; their perspective is 
vital to current and future technology success (IOM, 2010; Seckman, 2014).  Provider and 
clinician endorsement and continued use of PWPs are key factors in a patient’s decision to use a 
PWP (Logue & Effken, 2012; Wald, Businger, Gandhi et al., 2010).  Knowledge of PWPs and 
support of its use by nursing is crucial to the sustainability of this technology since nurses often 
are a key source of patient portal activation.  
This study contributes to the knowledge of nursing practice as it relates to PWPs by 
describing the patient characteristics of users versus nonusers of this technology for GDM self-
management.  This has the potential to better inform nursing on the similarities and differences 
of users and nonusers of PWPs so future modifications to PWPs can occur to either engage the 
nonusers or tailor patient education to meet the needs of these patients.  This study also reveals 
the frequency by which specific features of the PWP were accessed and the patterns of use.  This 
could prove valuable in providing insight on the key elements of PWPs for self-management. 
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This and future studies could determine if there are certain features of a PWP that should be 
included in all PWPs in order to work towards determining national standards for PWPs or if 
variations should exist to meet the needs of specific populations and conditions. 
PWPs are a form of technology that applies to nursing informatics. Nursing informatics is 
identified as and has been recognized as a specialty by the American Nursing Association (ANA) 
since 2001 (ANA, 2001).  Nurse informaticists have the ability to guide PWP engagement 
through their design and evaluation, determining what is relevant and user-friendly for portal 
users. This research can add to the nursing body of knowledge as it pertains to GDM PWP use. 
Theory 
This study contributes to theory by utilizing and building upon concepts within Ryan and 
Sawin’s IFSMT (2009).  While the tenets of the IFSMT are not tested, the variables of this study 
represent the context, process, and outcomes domains of the Ryan and Sawin (2009) theory and 
this theory guided this study.  This study extends the use of the IFSMT theory beyond chronic 
conditions into a more acute realm that is unique to pregnancy.  Furthermore, it tests the 
utilization of a technology tool to aid in self-management.  While this study does not determine 
if there is a direct correlation between PWP use/engagement and improved glycemic control, it 
provides some insight into the patient characteristics of PWP users and nonusers and guides 
future research that can further explore this relationship. This could subsequently inform future 
research about whether PWP use contributes to self-management. 
Research 
Meaningful Use, EHRs, and PWPs continue to evolve.  The HITECH Act of 2009 and 
Meaningful Use incentives have accelerated EHR adoption and they have been the major drivers 
for PWP adoption (Gibson, 2014; Irizarry et al., 2015). It is clear that PWP use will continue to 
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be an integral part of the EHR and a means to meet Meaningful Use incentives in the foreseeable 
future.  What is less clear is the population who will most likely benefit from these portals.  
Some research has been conducted on the positive impact of patient portals relative to chronic 
disease management such as cardiac disease or diabetes (McMahon et al., 2005; Quinn et al., 
2008; & Fonda et al., 2009).  There has been little research on more acute conditions or 
preventative management of health. 
This research aims to provide insight into the patient characteristics of users and nonusers 
of a PWP for GDM self-management and outline the features of the PWP used and patterns of 
use.  This research contributes to the increasing body of knowledge related to PWP use for a 
unique population that is non-chronic care related.   
Policy 
This study has the potential to influence policy on several levels.   At a local level it may 
influence policy at this health care organization.  At a broader level, this study may contribute to 
the body of knowledge related to Meaningful Use.  Stage 3 of the CMS EHR incentive program 
for Meaningful Use is scheduled to begin in 2017 and focuses on outcomes. The third stage is the 
use of EHR data to improve health outcomes, quality, safety, efficiency, and population health at 
the national level.  The EHR will likely focus on self-management and shared management of 
health care including increased use of PWPs (Gibson, 2014; HealthIT, 2013).   
There are several Meaningful Use measures that directly relate to the functionality of a 
PWP including (1) secure messaging, (2), clinical summary after each visit, (3) patient specific 
education, (4) patient reminders, (5) access to personal health record  information, and (6) 
medication reconciliation (Ahren, Woods, Lightowler, Finley, & Houston, 2011; Irizarry et al., 
2015). However, policy makers have yet to define the minimal criteria of a PWP and the 
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principles for an ideal PWP as they have for an EHR.  This clarity will be necessary for future 
research and advancement of this technology.  
This study addresses the specific patient characteristics of users and nonusers of a PWP 
for GDM self-management. If an expectation of Meaningful Use is to engage 5% of patients in 
the use of PWPs, it is essential that we understand the patient characteristics of users and 
nonusers (Irizarry et al., 2015). Understanding the differences between users and nonusers 
provides an avenue for future research on how to better tailor PWPs to convert nonusers to users 
before health policy dictates a certain practice.  Finally, the research findings may point to 
patient characteristics such as insurance type, co-morbidities, or type of GDM that should be 
understood before financial incentives or penalties are instituted through Meaningful Use for this 
population. 
Chapter Summary 
This chapter proposes a study to fill a gap in the literature on the effective GDM 
management and e-strategies to promote GDM self-management using PWPs. Studies exist 
demonstrating a relationship between the use of PWPs and improvements in hemoglobin A1c 
(HgA1c) in type 1 and type 2 diabetes however; only one study exists for GDM (Carolan, Steele, 
& Krenzin, 2015; McMahon et al., 2005; Quinn et al., 2008).  
The study purpose and research questions were outlined in this chapter.  The theoretical 
framework for the study was explained along with rationale and illustration of the link between 
the study variables and the IFSMT.  In addition, study concepts were defined and assumptions 
discussed.  Finally, the significance to nursing practice, theory, research, and policy was 
explained and expected limitations were discussed. 
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Chapter 2 
Review of Literature 
The layout of this chapter is structured to provide the reader with an in depth look at the 
literature on gestational diabetes, self-management, and patient web portals.  The chapter begins 
with an overview of GDM including pathophysiology, diagnosis and management, and maternal, 
fetal, and newborn effects.  Next, literature is reviewed on self-management in general and then 
more specifically related to GDM self-management.  The final section of this chapter discusses 
EHR technology, specifically the use of PWPs, their functionality, their role in self-management 
with other conditions, and the overall proposal to study this technology for GDM self-
management. 
Information in this literature comes from electronic searches of computerized databases, 
journals, and texts.  EBSCOhost Research Database, PubMed, Google Scholar, The Cumulative 
Index to Nursing and Allied Health Literature (CINAHL), and Cochrane Database of Systematic 
Reviews were the databases used for this literature review.  Other non-peer reviewed 
publications such as HealthIt.gov and Health Information Management Systems Society 
(HIMSS) were used for context and specific examples relative to PWPs. 
The following search terms were employed to capture the literature: “patient web 
portals”; “e-health and gestational diabetes”; “patient web portals and diabetes”; “gestational 
diabetes self-management”; and “self-management”. Bibliographies and literature reviews from 
identified articles were used to identify additional studies. All publications were published in 
English. The publications ranged from 1976 through 2016.  The earlier publications were used in 
reference to the physiology and diagnosis of GDM while more recent literature was referenced in 
terms of PWPs due to the rapidly evolving technology.  
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GDM 
Gestational diabetes mellitus (GDM) is the most common medical complication in 
pregnancy (Carr & Gabbe, 1998).  The prevalence of GDM in the United States is as high as 9.2 
percent according to a recent analysis performed by the Center for Disease Control and 
Prevention (DeSisto, Kim, & Sharma, 2014) and is projected to increase in the future.  GDM is a 
result of insulin resistance and impairment of insulin secretion (American Diabetes Association 
[ADA], 2016). The identification and treatment of women with GDM is important to not only 
prevent perinatal morbidity but also improve long-term outcomes for mothers and their children.  
Pathophysiology 
         There are many metabolic changes that occur in pregnancy to support the growing fetus. 
For example, early in pregnancy, maternal estrogen and progesterone increase, which result in 
pancreatic ß-cell hyperplasia and increased insulin release (Kuhl & Holst, 1976).  As pregnancy 
progresses, increased levels of progesterone, estrogen, and other hormones lead to insulin 
resistance in peripheral tissues, which causes the pancreas to release more insulin to respond to 
the insulin resistance (Carr & Gabbe, 1998).  Patients with normal pancreatic function are able to 
meet the increased demands however; patients with altered pancreatic function have difficulty 
increasing insulin secretion and therefore produce inadequate levels of insulin. GDM occurs 
when there is delayed or insufficient insulin secretion in the presence of increasing peripheral 
resistance (ADA, 2016). Cortisol and progesterone have their highest potency and peak effect 
between 26 and 32 weeks gestation, which is important in regard to GDM screening timelines 
(Carr & Gabbe, 1998).  
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Diagnosis 
In 1997,  an Expert Committee on the Diagnosis and Classification of Diabetes Mellitus,  
stated that universal screening may not be needed in women who meet all of the following 
criteria: 1) <25 years of age, 2) normal body weight, 3) no first-degree relatives with diabetes 
mellitus, 4) not African American, Native American, Asian, or Hispanic (ADA, 1997). In 2013, 
the American College of Obstetricians and Gynecologists (ACOG) recommended that all 
pregnant patients be screened for GDM based on risk factor identification or administration of 50 
gram oral glucose challenge test (OGCT). Other organizations feel that screening by risk factors 
is inadequate, since almost half of all patients with GDM have no identifiable risk factors 
(Coustan, 1995). Proponents of universal screening for GDM stress that pregnancy is an 
opportune time to diagnosis this disease that has both short and long-term effects on mothers and 
babies (Carr & Gabbe, 1998).  The setting for this study performs universal screening. 
  Screening methods. There are two methods of screening for GDM. In the 2-step 
approach, the 50-gram OGCT is performed between 24 and 28 weeks of gestation in a non-
fasting state (U.S. Preventive Services Taskforce, 2015). If the screening threshold is met or 
exceeded, patients receive the oral glucose tolerance test (OGTT) (ACOG, 2004). A threshold of 
140 mg/dl identifies roughly 90 percent of GDM cases with 15 percent of pregnant patients 
meeting criteria to take the 3-hour OGTT (ACOG, 2004).   During the OGTT, a fasting glucose 
level is obtained. Then the patient is given a 100 gram glucose load and glucose levels are 
evaluated after 1, 2, and 3 hours. GDM is diagnosed when 2 or more glucose values fall at or 
above the specified glucose thresholds.  
When the results of the 1 hour, 50 gram glucose screen results are >185 or a fasting 
glucose is >126, the patient does not need to proceed with the 3-hour OGTTA due to the risk to 
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produce hyperglycemia (Landy, Gomez, & O’Sullivan, 1996).  In these instances, the diagnosis 
of GDM can be assumed and treatment should begin.  
The 3-hour OGTT should begin after an overnight fast for at least 8 hours, following at 
least 3 days of unrestricted diet (>150 g carbohydrate) and usual physical activity (Carr & 
Gabbe, 1998).  After the 100 gram glucose load is delivered, venous plasma glucose is measured 
at fasting and at 1, 2, and 3 hours. ACOG recommends that two or more of the National Diabetes 
Data Group (NDDG) values be met or exceeded to make the diagnosis of GDM (ACOG, 2004). 
Alternatively, a one time, 75-g glucose load can be administered after fasting and plasma 
glucose levels are evaluated after 1 and 2 hours (ADA, 2016). Gestational diabetes is diagnosed 
if 1 glucose value falls at or above the specified glucose threshold (U.S Preventative Services 
Taskforce, 2015).  The 1 step approach has the potential for the identification of women with 
GDM to nearly double (Metzger, 2010). The 2-step approach to screening is used at this study 
setting.  
Other considerations. Patients with certain factors, such as a history of a prior 
macrosomic fetus, family history of diabetes, or chronic steroid use, may benefit from earlier 
testing, at or before 20 weeks gestation (Gabbe, 1993).  Testing can be repeated later in the 
pregnancy around 32 to 34 weeks with an initial negative result. A study by Javanovic and 
Peterson (1985) found GDM detection increased by about 50 percent by repeating the test at 33 
to 36 weeks gestation in high-risk women who were obese, age >33 years,  or a positive 1-hour 
screen followed by a negative OGTT.  
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Maternal effects 
Pregnancy/birth complications. Mothers with poorly controlled gestational diabetes 
mellitus are at increased risk for many complications during pregnancy and later in life. Study 
results have found that women with poorly controlled GDM have increased incidence of 
cesarean delivery, preterm delivery, and preeclampsia (Bellamy et al.,2009; Langer et al., 2005; 
Yogev, Xenakis, and Langer, 2004). A prospective cohort study conducted by Sermer and 
associates (1995) evaluated maternal and fetal outcomes with increasing carbohydrate 
intolerance and found  associations between glucose intolerance and increased incidence of 
preeclampsia, cesarean delivery, and maternal length of hospitalization (P<0.05). In addition, a 
key research study of over 25,000 women called the Hyperglycemia and Adverse Pregnancy 
(HAPO) study found  associations between elevated fasting plasma glucose and increased 
primary cesarean section delivery and preeclampsia (P<0.05, OR  primary cesarean delivery 
=1.11, OR preeclampsia= 1.21)  (HAPO, 2008). 
  Type 2 diabetes. Women with GDM are 2-3 times more likely to develop GDM with 
subsequent pregnancies and have a 7 times greater risk of developing type 2 diabetes later in life 
(Bellamy et al., 2009). Coustan (1993) studied former GDM women and found diabetes or 
impaired glucose tolerance (IGT) in 6 percent of those tested at 0–2 years, 13 percent at 3–4 
years, 15 percent at 5–6 years, and 30 percent at 7–10 years postpartum (P<0.001).   A study by 
Metzger and associates (1985) report a prevalence of 38 percent up to one year postpartum. A 
systematic review of 28 studies by Kim, Newton, and Knopp (2002) concluded that most women 
progressed to diabetes at a similar rate in the first five year post pregnancy and then leveled off 
by 10 years. However, there remains some controversy on the overall risk, due to a large 
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Canadian study of more than 25,000 women that reported only a small increased risk of Type 2 
diabetes to previous GDM women later in life (HAPO, 2008).  
Other complications. The implications of GDM are significant, since women with prior 
GDM are at greater risk for developing hypertension, hyperlipidemia, and mortality (O’Sullivan, 
1984).  Women with GDM are also predisposed to later cardiovascular disease (CVD) ( Reece, 
2010).  Carr et al., (2006) also compared women with and without a history of GDM and found 
that those with prior GDM were more likely to have CVD risk factors including metabolic 
syndrome (86.6 vs. 73.5%; P < 0.001) and Type 2 diabetes (93.4 vs. 63.3%; P < 0.001).  They 
also experienced more CVD events at a younger age (15.5 vs. 12.4%; adjusted odds ratio 1.85 
[95% CI 1.21-2.82]; P = 0.005) (Carr et al. 2006).  
Fetal/Newborn effects 
Anomalies. Infants of mothers with GDM are not at increased risk for congenital 
anomalies unless the woman had pre-existing diabetes mellitus and suboptimal glycemic control 
before conception (Carr & Gabbe, 1998). In these cases, the anomaly rate has been reported to be 
as high as 18% primarily involving the cardiovascular and central nervous system of the fetus 
(Becerra, Khoury, Cordero, and Erickson, 1990).  Neural tube defects, genitourinary, 
gastrointestinal, and skeletal anomalies are also more common in diabetic pregnancies (Moore, 
2016).  Fortunately, clinical trials of intensive metabolic programs have reduced anomaly rates to 
those similar to the nondiabetic women when strict pre-conceptional glycemic control is evident 
(Dunne, Brydon, Smith, & Gee, 2003).  
Miscarriage. It is also important to note that data suggests a strong association between 
the degree of glycemic control before pregnancy and the miscarriage rate. Poor glycemic control 
has been shown to double to quadruple the miscarriage rate in women with diabetes (O’Sullivan, 
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Charles, Mahan, & Dandrow, 1973; Pettitt, Knowler, Baird, & Bennett, 1980).  Additionally, 
women with long-standing (>10 years) and poorly controlled diabetes (glycohemoglobin 
exceeding 11%) have been shown to have a miscarriage rate of up to 44% (Moore, 2016). 
Macrosomia. Newborns of mothers with poorly controlled GDM have higher rates of 
macrosomia and birth injuries such as fractures or nerve damage (Alwan, Tuffnell, & West, 
2009).  Macrosomia complicates about 20 percent of GDM pregnancies and is defined as fetal 
weight >90th percentile for gestational age or >4,000 g (Kc, Shakya, & Zhang, 2015).  Maternal 
hyperglycemia leads to fetal hyperglycemia and fetal hyperinsulinemia, which results in excess 
fetal growth. Macrosomic fetuses display a distinct growth pattern with overgrowth occurring in 
the abdominal and intrascapular areas (McFarland, Trylovich, & Langer, 1998).  The increased 
growth in the shoulder region and not the head puts the fetus at risk for shoulder dystocia during 
delivery (Kc et al., 2015). 
Shoulder dystocia is increased two- to six-fold in fetuses of GDM mothers and even 
further increased in newborns with fetal weight greater than 4000 grams (Moore, 2016).  A 
brachial plexus injury is a serious complication associated with shoulder dystocia and involves 
the loss of movement or weakness of an arm from the stretching and pulling of the shoulders 
during vaginal delivery (Benedetti, 1991).   Most brachial plexus injuries (80–90 percent) will 
resolve in the first year however; between 0.2 percent and 2 percent will result in permanent 
injury (Blank & Grave, 1992). 
Obesity. Many studies highlight the increased risk of obesity in children born to mothers 
with GDM.  This generational cycle of obesity further perpetuates the risk and incidence of 
future pregnancies with GDM.  Children who were born to mothers with GDM have double the 
rates of obesity compared to children born to nondiabetic mothers (Plagemann, Harder, 
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Kohlhoff, Rohde, & Dorner, 1997; Silverman, Metzger, Cho, & Loeb, 1995; Vohr & Boney, 
2008).  Pettitt and associates studied the children of diabetic Pima Indians from 5 to 19 years of 
age and found a significantly higher body weight as compared to control subjects (Pettitt et al., 
1987). 
Type 2 diabetes. Children who were born to women with GDM or pregestational 
diabetes had 13 times the incidence of impaired glucose intolerance than children born to 
nondiabetic mother (Silverman et al., 1995).  Between the ages of  10-16 years, McKinney and 
associates found, children of a diabetic pregnancy had a 19.3% rate of impaired glucose intolerance 
(McKinney, Parslow, Gurney, Law, Bodansky, & Williams, 1999).  Fetuses that were born large for 
gestational age seem to be at the greatest risk (Eriksson, Forsen, Osmond, & Barker, 2003).  
Other complications. There are several other complications that are common among 
newborns born to GDM mothers including hypoglycemia, respiratory distress, and 
neurodevelopmental changes (Ferrara, 2004).  Neonatal hypoglycemia occurs in roughly 50 
percent of macrosomic infants. Control of maternal diabetes during the latter half of pregnancy 
and during labor and delivery influences the occurrence of neonatal hypoglycemia (U.S. 
Preventative Services Taskforce, 2015).  In addition, babies born to women with GDM have a 
higher incidence of respiratory distress syndrome (DeLuca et al., 2009). Although the reason is 
not completely understood, there is evidence that hyperglycemia delays fetal lung maturity thus, 
periods of poorly controlled diabetes could delay fetal lung maturity in fetuses born to mothers 
with GDM (DeLuca et al., 2009). Infants born to mothers with GDM are also at increased risk 
for long-term neurodevelopmental changes (Ferrara et al., 2004).  A study by Rizzo and 
associates of 196 pregnant women and their singleton children concluded that children had 
poorer performance of psychomotor development at 6 and 9 years of age if their mother had 
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GDM or pregestational diabetes during pregnancy (P<0.001)(Rizzo, Dooley, Metzger, Cho, 
Ogata, & Silverman, 1995).  
Clearly, the detection and appropriate management of GDM provides the opportunity to 
prevent adverse outcomes for both mothers and their children. 
Management 
 After the diagnosis of GDM is established, treatment is focused on diet/nutrition, 
exercise, and glucose monitoring (ADA, 2016).   
Nutritional therapy.  Diet or nutrition therapy is an important component of GDM 
management that often includes nutritional counseling and a personalized nutrition plan with the 
goal of achieving normoglycemia and preventing ketosis (ACOG, 2013). The goal of dietary 
therapy is to avoid large meals and foods with a lot of simple carbohydrates by dividing meals 
into a total of 6 feedings per day, typically with 3 meals and 3 snacks to limit the amount of 
glucose circulating in the bloodstream at any given time (Moore, 2016).  A study by Gunderson 
reviewed intensive nutritional therapy, and emphasized limiting total carbohydrates and 
distributing carbohydrates throughout the day via several meals and snacks in order to maintain 
normal blood glucose levels (Gunderson, 1997). This is particularly important in pregnancy due 
to the continuous fetal draw of glucose from the mother so hypoglycemia can be avoided (ADA, 
2008). A minimum of 175 grams of carbohydrate/day should be given and may be increased or 
adjusted based on hunger, plasma glucose levels, and ketone levels (Institute of Medicine [IOM], 
2002).  
The American Diabetes Association recommends that carbohydrates should be no more 
than 50 percent of the women’s diet, with fats and protein accounting for the rest (ADA, 2013).  
However, Meltzer and colleagues noted that a carbohydrate restriction to 35 to 40 percent of the 
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diet decreased maternal glucose levels and improved maternal and fetal outcomes (Meltzer, 
Snyder, Penrod, Nudi, & Morin, 2010).  The ADA also notes that moderate caloric restriction of 
up to 30 percent of energy needs in obese women with GDM may reduce weight gain and 
improve glycemic control without ketonemia (ADA, 2008).  
Exercise. Exercise has been suggested as an adjuvant therapy in GDM, since exercise has 
shown to improve glycemic control in patients with GDM (Bung, Artal, Khodiguin, & Kjos, 
1991). Additional studies support the benefits of exercise on glycemic control.  A study by 
Jovanovic-Peterson and associates compared 50 women with GDM who were assigned to a 
dietary treatment with those assigned to diet plus exercise treatment.  The study results suggest 
significantly lower fasting blood glucose levels in the diet plus exercise group than diet alone 
(Jovanovic-Peterson & Peterson, 1990).  A meta-analysis of exercise and pregnancy studies 
conducted by Lokey and associates concluded that pregnant women can exercise up to 3 times 
per week for roughly 40 minutes with no harm to either herself or the fetus (P=.20) (Lokey, Tran, 
Wells, Myers, & Tran, 1991). 
Glucose monitoring. Hemoglobin A1c (HbA1c) has been an accepted marker of 
glycemic control since the mid-1970s and is clinically used to assess glycemic control in people 
with diabetes (Saudek & Brick, 2009). In pregnancy, however, A1c may not be the most reliable 
measure of glycemic control due to normal physiological increases in red blood cell turnover, 
resulting in reduced A1c levels (Nielsen et al., 2004). Furthermore, A1C is an integrated measure 
of glucose and may not fully detect postprandial hyperglycemia, which drives macrosomia 
(Nielson et al., 2004).  As a result, blood glucose self-monitoring and targets are the primary 
measures of glycemic control in women with GDM.  It is also the outcome measure of this study.  
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According to ACOG, there is insufficient evidence to outline the optimal frequency of 
glucose monitoring but the general recommendation is four times daily, one fasting and then 1 or 
2 hours postprandial (ACOG, 2013). The most recent American Diabetes Association (ADA) 
guidelines for diabetes in pregnancy glucose monitoring targets are: fasting ≤95 mg/dL (5.3 
mmol/L) and; one-hour postprandial ≤140 mg/dL (7.8 mmol/L) or two-hour postprandial ≤120 
mg/dL (6.7 mmol/L) (ADA, 2016).  These targets may result in hypoglycemia for some 
individuals thus the ADA recommends, in these cases, less stringent targets based on clinical 
experience and individualized care (ADA, 2016).  
Postprandial glucose measurements are preferred over preprandial measurements.  A 
retrospective study of women with GDM experienced lower glycosylated hemoglobin values and 
had fewer macrosomic babies when postprandial glucose values were used (Major, deVeciana, 
Morgan, & Henry, 1993).  In a follow up randomized trial of 42 women, de Veciana and 
colleagues concluded that fasting and 1-hour postprandial glucose monitoring demonstrated 
improved glycemic control and decreases in shoulder dystocia, hypoglycemia, macrosomia, and 
cesarean delivery in comparison to preprandial glucose monitoring (de Veciana et al., 1995). 
Medication. Women who cannot maintain blood glucose levels within target ranges or 
women who have greater initial degrees of hyperglycemia may require pharmacological therapy. 
Insulin is the first-line agent recommended for treatment of GDM in the U.S. (ADA, 2016).  The 
ACOG criteria for initiating insulin therapy include a fasting plasma glucose level >105 mg/dl 
and 2-hour plasma postprandial levels >120 mg/dl
 
(ACOG, 2013).  If insulin is required, the 
target plasma glucose levels are fasting glucose value 60–90 mg/dl, preprandial value 60–105 
mg/dl, 2-hour postprandial value <120 mg/dl, and 1-hour postprandial value not >130-140 mg/dl 
(ACOG, 2013; ADA, 2016).   
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Pharmacologic therapy with oral agents such as glyburide and metformin are becoming 
more popular. Randomized controlled trials demonstrate the efficacy and short-term safety for 
mother and fetus when administering metformin (pregnancy category B) and glyburide 
(pregnancy category B) although the potential for long-term adverse effects remains unclear 
(Coustan, 2007; Langer, Conway, Berkus, Xenakis, & Gonzalez, 2000; Rowan, Hague, Gao, 
Battin, & Moore, 2008). Metformin may be the preferable over insulin for maternal health but 
holds a higher risk of prematurity (Balsells, Garcia-Patterson, Sol al Roque, Gich, & Corcoy , 
2015).   
 Outcomes. Studies exist that point to improved perinatal outcomes when treatment 
includes nutrition therapy, blood glucose monitoring, and insulin therapy when needed.  In a 
study by Crowther and associates, 1000 women with GDM were randomized to an intervention 
group (dietary advice, blood glucose monitoring, and insulin therapy) or routine care (Crowther, 
Hiller, Moss, McPhee, Jeffries, & Robinson, 2005).  The 490 women in the intervention group 
experienced significant reductions in complications such as large for gestational age newborn, 
shoulder dystocia, and perinatal death (1% vs. 4%, P= 0.01) (Crowther et al., 2005). Langer and 
colleagues expressed similar findings in their matched controlled study of nondiabetic women, 
women treated for GDM ,and women diagnosed with GDM after 37 weeks gestation (Langer et 
al., 2005). Untreated women experienced a two to four fold increase in macrosomia and 
metabolic complications (Langer et al., 2005). 
Self-Management 
Concept 
The concept of self-management is widely used in the literature, yet it differs across 
disciplines, programs of research, and authors (Ryan & Sawin, 2009).  Self-management can be 
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described as a group of daily behaviors that individuals perform to manage a condition (Glasgow 
& Anderson, 1999).  It is a dynamic process in which individuals and families engage in 
processes to improve their health versus comply with prescribed orders (Ruggiero et al., 1997). 
The vast majority of self-management research resides in chronic disease management 
and has resulted in numerous self-management frameworks (Corbin & Strauss, 1988; Grey, 
Knafl, & McCorkle, 2006; Lorig & Holman, 2003; Ryan & Sawin, 2009).  Corbin and Strauss 
(1988) categorized the chronic disease self-management (CDSM) behaviors into three realms: 
(1) medical management, (2) adopting new behaviors, and (3) dealing with emotions.  In 2001, 
Lorig, Sobel, Ritter, Laurent, and Hobbs outlined five core self-management behaviors that are 
seen in most chronic conditions: problem solving, decision making, resource utilization, forming 
of a relationship with a provider, and taking action. Later,  Lorig and Holman (2003) and Unger 
and Buehlow (2009) further defined CDSM as the actions people take to manage their chronic 
disease and its effects including medication and treatment compliance, safety, event 
management, and lifestyle management.  
Grey et al. (2006) expanded self-management knowledge by including the family in their 
framework as well as suggest its application beyond those already diagnosed with a chronic 
illness. The authors state that their framework provides an approach for “understanding, 
development, and testing of self- and family-management interventions for people with chronic 
conditions, or at risk for their development” (Grey et al., 2006, p. 281). Their Self and Family 
Management Framework outline risk and protective factors along with outcomes of self-
management.  
  Ryan and Sawin (2009) further incorporate the family into their Individual and Family 
Self-Management Theory (IFSMT). The IFSMT combines previous research on Ryan’s 
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Integrated Theory of Health Behavior Change (ITHBC) and Sawin’s Ecological Model of 
Secondary Conditions and Adaptation into one framework with context, process, and outcomes 
dimensions. The context dimension includes risk and protective factors including physical and 
social environment, condition specific factors, and individual/family characteristics.  
The processes dimension of the IFSMT encompasses knowledge and beliefs, self-
regulation of skills and abilities, and social facilitation.  Ryan and Sawin (2009) include the 
actual engagement of self-management behaviors as a proximal outcome of their Individual and 
Family Self-Management Theory (IFSMT) while distal outcomes are health status, quality of 
life, and cost of health.    
While most of the existing research on self-management theory revolves around chronic 
conditions, the IFSMT expands its utility into health promotion and more acute conditions.  A 
2013 study by Doering used the IFSMT when exploring the physical and social environment of 
sleep self-management in postpartum women. In addition, Ryan and colleagues are currently 
engaged in research on an osteoporosis prevention app using the IFSMT (NIH Reporter).  
Recently, Shulman-Green et al., (2012) completed a metasynthesis of 101 self-
management articles to describe the processes of self-management.  The authors identified three 
categories of self-management processes: 1) focusing on needs due to the chronic condition; 2) 
activating resources; and 3) living with a chronic illness (Shulman-Green et al., 2012).  The 
synthesis also outlined additional task and skills mentioned in the articles.  It is surprising that 
the use of computers, patient portals, or secure messaging was not a skill listed. 
In this day in age of technology evolution and governmental financial incentives for EHR 
use, it seems logical to research and incorporate technology into self-management frameworks. 
There is a growing body of evidence that self-management interventions and programs improve 
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outcomes in individuals with chronic illnesses (Ryan & Sawin, 2009). Yet, little research exists 
on the impact self-management interventions can offer for more acute conditions or health 
promotion. This research will further expand the use of the IFSMT to the GDM population 
incorporating self-management concepts using a PWP as a technology based intervention. 
GDM Self-management 
While the emphasis of treatment for GDM is on dietary modifications, exercise, and 
blood glucose monitoring, a standard on how to implement strategies for successful self-
management is lacking.  Literature on GDM self-management is primarily qualitative and 
identifies themes associated with diagnosis and management of GDM and barriers or facilitators 
to GDM self-management.   
Themes. Several qualitative studies exist on the lived experience of women with GDM 
(Abraham & Wilk, 2014; Devsam, Bogossian, & Peacock, 2013; Morrison, Lowe, & Collins, 
2014).  While the number of themes and titles varied among the studies, common themes in all 
the studies revolved around initial shock and emotions with diagnosis of GDM, adapting to 
GDM, social support, and staying healthy to prevent Type 2 diabetes.  
Morrison and colleagues conducted a postal survey of the experiences of women with 
GDM in Australia and outlined eight themes: 1) shock, fear, and anxiety, 2) uncertainty and 
skepticism, 3) opportunity to improve one’s health, 4) adapting to life with GDM, 5) the need for 
support, 6) better awareness, 7) abandoned, and 8) staying healthy and preventing diabetes.    
Women taking insulin were more likely to feel shock, fear, and anxiety (p= 0.001).  
Similarly, Abraham and Wilk (2014) conducted a phenomenological study of 10 women 
with a history of GDM within the last five years.  They identified five themes: 1) Authentic 
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emotion; 2) Judgement; 3) It’s only a matter of time; 4) I can’t do this alone; and 5) Missed 
opportunities.  
Devsam et al. (2013) performed an interpretive review of women’s experiences with 
GDM that incorporated both qualitative and quantitative research. Nineteen studies were 
reviewed and  three themes were identified: 1) Responses which included the core concepts of 
initial response to GDM, negative thoughts about GDM, struggle to manage GDM, loss of 
control, changes to identity, and adapting to change; 2) Focus of concern with core concepts of 
concern for baby’s health, concern for own health, perceived seriousness of GDM, perceived fear 
of Type 2 diabetes; and 3) Influencing factors with core concepts of cultural roles and beliefs, 
social support and stigmas, professional support, adequate information, and barriers to self-care. 
The authors propose using these themes as a guide when caring for women with GDM. 
Facilitators/Barriers. Studies suggest that facilitators to health behavior change after 
diagnosis of GDM  are concern for the health of the baby, to stay healthy for the other children, 
to be a role model for the children, and desire to avoid type 2 diabetes (Devsam et al., 2013 ).   
 Barriers identified in the literature include lack of motivation, lack of time, lack of clear 
and timely information, and lack of interventions that fit into women’s multiple roles as 
caregivers, workers, and patients (Parsons, Ismail, Amiel, & Forbes, 2014).  The dietary and 
activity modifications required may be difficult for many women due to their current lifestyle 
habits and as a result many women struggle to adhere to GDM guidelines (Carolan, Gill, & 
Steele, 2012;  Hui et al., 2014).  
Research findings suggest that effective glycemic control is a vital component to good 
maternal and fetal outcomes, which is influenced by a woman’s self-management behaviors 
(Carolan et al., 2010).  While many women feel they have knowledge related to GDM, they often 
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seek additional information through family, friends, and online sources.  Women in the Hui et al. 
(2014) study felt the dietary information they were given by providers was insufficient and was 
not meeting their personal needs.  Women felt frustrated about the limited amount of time they 
had to adapt their lifestyle choices and they also felt the information was not tailored to them 
specifically (Hui, 2014).  
Recognizing the barriers and facilitators to GDM self-management is a first step to 
designing interventions and programs to promote GDM self-management. Very few studies exist  
in the literature related to GDM self-management interventions despite literature supporting  the 
value of  GDM self-management on reducing obesity,  reducing pregnancy complications, and  
improving glycemic control (Cheung, 2009; Glastras & Fulcher, 2012).   The majority of studies 
focus on type of medical management including medication and the threshold for glycemic 
control (Alwan et al., 2009).   
GDM Interventions. To address this gap, Carolan (2015) conducted an integrative 
review of the literature to guide GDM management.  The goal of the review was to provide 
background information for the development of future GDM management programs and 
interventions.  Twelve papers were reviewed and all of them used quantitative methods with 
comparison groups (Carolan, 2015).   The results of the review indicated that GDM interventions 
fall into three categories: (1) self-monitoring of blood glucose levels, (2) dietary and exercise 
interventions, and (3) behavioral interventions/counseling.  These interventions reduced insulin 
requirements, reduced macrosomia, and improved knowledge and pregnancy outcomes 
(Brankston, Mitchell, Ryan, & Okun, 2004; Carolan, 2015; Hoppichler & Lechleitner, 2001; 
Landon et al., 2009; Moses, Barker, Winter, Petocz, & Brand-Miller, 2009).   
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Use of Technology. Most of the research on GDM self-management has been with in-
person education and counseling (Mendelson, McNeese-Smith, Koniak-Griffin,  Nyamathi, & 
Lu, 2008; Murphy, Guilar, & Donat, 2004) despite the successful outcomes using telehealth and 
PWPs among people with type 1 and type diabetes (Po, 2000).  This author was only able to find 
two studies related to the use of such technology for GDM self-management. 
 Ferrara et al. (2012) studied whether a referral to a nurse-based management program 
that offered supplemental GDM care via telephone counseling on diet, activity and blood glucose 
monitoring was associated with improved perinatal outcomes as defined by macrosomia low 
birthweight babies, and postpartum glucose testing. This was a multicenter, retrospective study 
of 12 medical centers with over 11,000 subjects.  The results suggest that receiving care at the 
centers with higher referral frequency (>70%) compared to those with lower referral frequency 
(<30%) for telephonic nurse management for GDM was associated with decreased risk of 
macrosomic infant and increased postpartum glucose testing (multiple-adjusted odds ratio, 22.96; 
95% confidence interval, 2.56 –3.4 and multiple-adjusted odds ratio, 0.75; 95% confidence 
interval, 0.57– 0.98) (Ferrara et al., 2012).  
In the second study, Carolan, Steele, and Krenzin (2015) created a web-based GDM 
intervention aimed at multi-ethnic women in Melbourne, Australia.  A pretest/posttest design 
explored the impact of the intervention on GDM self-management principles, knowledge of 
GDM, and food values for 21 women with GDM using the Knowledge of GDM questionnaire.  
Results suggested that the intervention was effective in improving knowledge scores but less 
effective in improving food values and self-management principles. The Fisher’s Exact test P-
value for the association between GDM score improvement and education was 0.294; the 
association between food score improvement and education was 0.347; and the association 
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between self-management score improvement and education was 0.170. The authors explain that 
a misunderstanding of specific survey questions and interpretation of the web resource may have 
contributed to the lower improvement noted in the self-management area (Carolan, Steele, & 
Krenzin, 2015).  Revisions will be made and the authors have plans for a clinical trial. 
While the number of themes and titles varied among studies, common themes identified 
in women with GDM revolve around initial shock and emotions with diagnosis of GDM, 
adapting to GDM, social support, and staying healthy to prevent Type 2 diabetes. Furthermore, 
facilitators to health behavior change after diagnosis of GDM include concern for the baby’s 
health, desire to stay healthy for their other children, be a role model to their kids, and desire to 
avoid type 2 diabetes (Devsam et al., 2013 ).  These themes and facilitators offer insight into the 
emotional journey and motivation for health behavior change among women with GDM. 
Barriers identified in the literature such as lack of time, lack of clear and timely information, and 
difficulty adjusting to diet modifications point to the struggles women with GDM experience and 
should be addressed when designing future interventions to care for this population. Literature on 
the interventions for GDM self-management revolve around three topics; self-monitoring of 
blood glucose, diet and exercise, and behavioral interventions.  
Web-based patient portals for GDM management have the potential to address the 
facilitators and barriers noted above and could potentially provide a cost-effective alternative to 
strictly in-person diabetes clinic visits.  For instance, portals can be accessed at any time so 
timely information could be a benefit of a portal designed for GDM management. The limited 
existing research on PWP use and other health information technology interventions for GDM 
self-management is worth further exploration and is the intent of this research study. 
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Patient Web Portals 
History 
Patient web portals were first introduced and adopted by large health care organizations 
in the late 1990s (Halamka, Mandl, & Tang, 2008).  It was not until about 2006 that patient web 
portals gained widespread use due to the launch of personal health records (ePHRs) by Microsoft 
and Google and the general public’s adoption to communication sharing tools like social media 
and smartphones (Weitzman, Kaci, & Mandl, 2009).  Ultimately, the main driver of PWP 
adoption and sustainability is the meaningful use (MU) criteria set forth by the Centers for 
Medicare and Medicaid Services (CMS) EHR incentive program as part of the American 
Reinvestment and Recovery Act of 2009 (Wright, Feblowitz, Samal, McCoy, and Sittig, 2014).  
PWPs could be viewed as a transformative piece of technology that offers unlimited online 
access to online health information and care however; simply building a PWP will not ensure its 
use or success (National Learning Consortium, 2013; Weingart, Rind, Tofias, & Sands, 2006). 
The PWP needs to be user-friendly, engaging, and structured in a manner that supports patient-
centered outcomes. Furthermore, the PWP should be integrated into clinical practice so it 
becomes part of the care delivery model and method to communicate with patients, provide 
support, and information (National Learning Consortium, 2013). 
Definition 
A PWP is an interactive internet-based website that allows patients and providers to 
communicate and give patients access to their medical record, review clinical data, graphs, and 
education points (Sorensen, Shaw, & Casey, 2009).  Patient portals are managed by a health care 
institution or health care provider.  The purpose of the portal concept is to engage patients in 
actively participating in their health care rather than being passive recipients of care (Shaw & 
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Ferranti, 2011). Irizarry, DeVito-Dabbs, and Curran (2015) describe a patient portal as an ePHR 
[electronic personal health record] that directly links, or is “tethered” to an EHR (p. 2).   
The  HealthIT.gov (2016)  definition is more specific stating that a patient portal is a secure 
online website that gives patients convenient 24-hour access to personal health information from 
anywhere with an Internet connection.  While most of these definitions are similar in nature they 
lack clarity on the specific components of a PWP.  
HealthIT. gov’s definition includes a list of possible features that people can access 
within the portal such as discharge summaries, medications, allergies, and lab results.  They note 
that some patient portals also allow patients to request medication refills, schedule appointments, 
and secure message to healthcare providers (HealthIT.gov, 2013).  Meaningful Use requirements 
outline six specific functionalities of patient portals for their incentive program: (1) secure 
messaging, (2) clinical summaries after visits, (3), patient specific education, (4) patient 
reminders, (5) medication reconciliation, and (6) access to personal health information (Irizarry 
et al., 2015).    
Patient web portals (PWP) vary in their content and what is available for patients to view.  
This lack of clarity on minimal components of a patient portal creates confusion when designing 
a study or interpreting results.  Each study may incorporate a different set of PWP features which 
in turn could influence the results.  Generalizing the results beyond a specific institution can be 
difficult when common PWP features are not used.   
PWP Users 
 Definition. Variations exist within the literature on definitions and categories of people 
who use and don’t use patient web portals (Ronda et al., 2015; Sarkar et al., 2011; Weingart et 
al., 2006; Yamin et al., 2011).  The terms adopters and nonadopters were used in a 2011 study by 
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Yamin and associates regarding personal health record (PHR) use.  Adopters were those 
individuals who registered for the PHR and activated their account while nonadopters did not 
have an active account (Yamin et al., 2011).  A 2006 study by Weingart and colleagues, describe 
individuals as enrollees or nonenrollees of a patient portal called PatientSite. The terms users and 
nonusers of PWPs is all cited in studies (Ronda et al., 2015; Sarkar et al., 2011). Ronda and 
associates further classified patients into two groups: ‘early quitters’ and ‘persistent users’.  
For the purposes of this study nonusers apply to subjects who logged in only once.  
Short-term users were subjects who logged in during the first month after enrollment.  Persistent 
users were users that logged in throughout the third trimester.   
 While PWPs have shown to be an effective tool to promote diabetes self-management 
and received an overall positive reception by patients, adoption rates vary (McMahon et al., 
2005; Ronda et al., 2015).   Study results suggest that there are differences between users and 
nonusers of PWPs in regards to demographic and other variables (Osborn, Mayberry, Wallston, 
Johnson, & Elasy, 2013; Ronda et al., 2015).  These differences are important to understand so 
that PWP designs can be refined and individualized to meet the needs of specific individuals.   
 A case-control study of 200 patients by Weingart and colleagues (2006) found that 
PatientSite enrollees were younger, more educated, and had fewer medical problems than 
nonenrollees (P< 0.001). However, seven percent of users were at least age 65. Similar results 
were also noted in a 2015 study by Ronda and associates. Ronda and colleagues administered a 
survey to 1,500 type 1 and type 2 diabetes patients within 62 primary care clinics and one 
hospital outpatient clinic.  632 patients (42.1%) responded to the survey. Their study on the use 
of a diabetes PWP concluded that persistent users were younger (61.9 + 12.7 in early quitters vs. 
58.5 + 13.3 for persistent users, P=.02), employed (36.3 for early quitters vs. 47.1 in persistent 
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users, P= 0.01), and more often used insulin (45.9 in early quitters vs. 63.2 in persistent users, 
P<0.001) (Ronda et al., 2015).  
In contrast, a study by Sarkar (2011) of 14,102 adults with diabetes in Northern 
California concluded that older adults, those with less education (OR compared to college 
graduates, 2.3(1.9-2.7)) and African Americans and Latinos (OR 2.6(2.3-2.9); (OR 2.3(1.9-2.6)) 
were less likely to access a PWP.  However; those with computer access, older adults were more 
likely to use the PWP than younger adults.  Interestingly, Mayberry and colleagues identified 
family member support as a reason for why patients of all health and computer literacy levels 
might access and use PWPs (Mayberry, Kripalani, Rothman, and Osborn, 2011).  
 Gender. Several studies indicate that women adopt PWP technology more quickly than 
men (Fleming, Cullen, & Luna, 2015; Kruse et al., 2015).  This result is likely due to women 
having more interactions with the healthcare system. Even when reproductive visits (e.g., 
pregnancy, birth control) were removed, Courtenay  noted that women are encouraged to pay 
more attention to their health and seek routine care  (Courtenay, 2009 as cited in Broom & 
Tovey). Vaidya, Partha, and Karmakar (2012) also validated similar findings through a study that 
found women to be the highest consumers of preventative health services, perceiving PWPs as 
another form of preventative care and a way to stay updated about their health. 
 A review of 17 research studies by Emont (2011) on PWP use concluded that the 
majority of consumers are female and the most used features of the PWP are secure messaging, 
viewing lab results, scheduling appointments, and medication refill requests. Furthermore, the 
author suggests that people become more engaged in their health and medical care when their 
health information is accessible online (Emont, 2011).  Certainly this information is encouraging 
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to researchers of PWP intervention studies focused on women, particularly those focused on 
women.  
Outcomes. The use of patient web portals (PWP) as a tool to promote diabetes self-
management is prevalent in the literature (Fonda et al., 2009; Grant et al., 2008; Kim, Kim, & 
Ahn, 2006; McCarrier et al., 2009; Quinn, et al., 2008).   Many of the studies to date are 
randomized controlled trials that focus on the biological outcomes of hemoglobin A1c levels, 
blood pressure, and lipid levels (Fonda et al., 2009; Grant et al., 2008; Kim, Kim, & Ahn, 2006; 
McCarrier et al., 2009, McMahon et al., 2005; Noel, Vogel, Erdos, Cornwall., & Levin, 2004; 
Quinn et al., 2008).   
Several randomized and nonrandomized controlled studies demonstrate a decrease in 
hemoglobin A1c levels with PWP use (Fonda et al., 2009; Grant et al., 2008; Kim et al., 2006; 
Quinn et al., 2008).  See Table 3 for specific details on each study and results. Conversely, 
reductions in blood pressure and lipid levels with PWP use are not as conclusive nor are they as 
relevant in the gestational diabetes population (Grant et al., 2008; McMahon et al., 2005; Shaw 
& Ferranti, 2011).   
Research has also shown that PWP use is associated with lower diabetes distress scores.  
For example, a randomized controlled trial of 102 patients with type 1 and 2 diabetes found 
lower diabetes distress in subjects who used their PWP and the lowest diabetes distress scores 
among more frequent PWP users (Fonda et al., 2009).  Diabetes distress scores were measured at 
baseline and quarterly for 12 months using the Problem Areas in Diabetes (PAID) questionnaire. 
The PAID scores of sustained, regular users of the PWP  were 14.7 points lower that subjects 
who did not use the PWP (P=0.006).  
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Additionally, research exists related to the components of diabetes self-management such 
as self-efficacy and PWP use.  McCarrier and colleagues (2009) conducted a randomized 
controlled trial of 77 patients with type 1 diabetes to determine if a web-based case-management 
program in an EHR could improve glycemic control and diabetes-specific self-efficacy. The 
intervention group experienced a significant increase in diabetes-related self-efficacy compared 
to the usual care group (group difference of 0.30; 95% confidence interval 0.01 to 0.59; P = 
0.04). Self- efficacy is a key component to self-management (Ryan & Sawin, 2009).  
Research Gaps 
 
While studies exist related to counseling and educational programs for GDM self-
management, only one study was found in the literature on the use of a PWP for GDM self-
management (Carolan, et al., 2015).   Patient web portals have successfully been used to promote 
self-management in patients with type 1 and type 2 diabetes resulting in improved hemoglobin 
A1c levels (Kim et al., 2006; McMahon et al., 2005; Noel et al., 2004; Shaw & Ferranti, 2011; 
Smith et al., 2004).  This concept should be tested in the GDM patient where motivation is high 
and barriers to self-management include time and travel (Carolan et al., 2012).  Effective GDM 
self-management interventions have the potential to control glucose levels and reduce the risk of 
adverse outcomes for mothers and babies during pregnancy and later in life.  
Unfortunately, few intervention studies have been performed on this population of 
women.  Most of the literature is qualitative in nature and points out facilitators and barriers to 
GDM self-management.  There is solid evidence on the negative consequences for the mother 
and infant in terms of GDM and the importance of dietary modifications, exercise, and tight 
blood glucose monitoring.  In addition, evidence suggests and recognizes the need for resources 
and programs to promote GDM self-management (Carolan et al., 2010).  However there is a gap 
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in the literature on how best to promote GDM self-management, what resources and technology 
are most effective. 
  Furthermore, little is known about the patient characteristics of users and nonusers of 
PWPs and patterns of use (Jones et al., 2015).  Understanding how women with GDM use PWP 
is essential to refining this technology to further meet the needs of the patients, providers, and 
clinicians.   
Chapter Summary 
This chapter discussed the physiology, negative effects of GDM, and its management 
course to provide a foundation of evidence to this study topic. The concept of self-management 
and literature related to self-management for GDM was explicated. The literature on diabetes 
self-management with a focus on the use of technology was examined as was the literature on 
use of such technology for GDM self-management. Finally, literature on PWPs were synthesized 
including definitions, specific populations of users, and outcomes of PWP use in type 1 and type 
2 diabetes.  Research gaps were identified and the rationale for additional research related to 
GDM self-management using a PWP is outlined.  
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Chapter 3 
Methods 
Research Design 
The study was a retrospective cohort design that followed participants from entry into a 
diabetes and pregnancy clinic between 28 to 32 weeks gestation through childbirth, accounting 
for roughly a three month period of time. All patient care data and communication regarding the 
patient’s GDM care are documented within the same electronic health record (EHR). 
 A retrospective design was used for several reasons.  First, a prospective study would 
involve a great deal of time in order to obtain an adequate sample size (Polit & Beck, 2012).  The 
health care organization for this study cares for a total of about 100 women with GDM a year, 
which means a prospective approach would require recruiting patients for over two years and 
then tracking them for the last three months of their pregnancy.  With an estimated sample size 
for an experimental or quasi experimental design of 200 subjects the data collection period of a 
prospective study could be even longer.  A retrospective design provides a large sample size in a 
feasible amount of time.  
Setting/Sample 
The sample included all pregnant women in their third trimester with a diagnosis of GDM 
according to the International Classification of Diseases, ICD-9 and ICD-10 codes that were 
referred to and received services at a diabetes and pregnancy clinic in two hospitals in a 
Midwestern state in the United States.   The women received health care at the clinic between 
January 2013 and January 2016. 
Inclusion criteria were the following:  (a) age 18 years and older, (b) diagnosis of 
gestational diabetes (insulin or diet controlled), (c) in the third trimester of pregnancy but before 
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32 weeks gestation, and (d) singleton pregnancy.  Exclusion criteria were (a) women who first 
presented to the clinic after 32 weeks gestation due to the decreased ability to impact blood sugar 
numbers with less than three months of care, and (b) multiple gestation. 
An estimated sample size of 300 women was targeted for this study.  A power analysis 
was conducted using G*Power software indicating a sample size of 128 was needed with 80 
percent power for detecting a medium sized effect with 0.05 significance level assuming two 
groups (users and nonusers) in the ANOVA model (Faul, Erdfelder, Lang, & Buchner, 2007).   A 
sample size of 159 was needed with 80 percent power for detecting a medium sized effect with a 
0.05 significance level if there were three groups (nonusers, short-term users, persistent users) in 
the ANOVA model. This power analysis was performed and validated by Dr. Weiming Ke, 
University of Wisconsin-Milwaukee College of Nursing.  
Data Source  
The data sources for this study included a departmental Excel database, Epic EHR, and 
the MyChart server log files. Epic’s MyChart is the PWP portion of the Epic system. Epic’s 
MyChart is the most widely used patient portal according to a recent KLAS survey (Pennic, 
2012).  This healthcare organization has been utilizing Epic and portions of MyChart since 
October 2011. 
Patient Web Portal 
 Patients were able to activate their PWP by creating a username and password. Once 
activated, the patients were able to view their health information and utilize the features of the 
PWP. All women receiving care at the diabetes and pregnancy clinic received a log-in to access 
the PWP for health care purposes. At their first visit in the clinic, women were asked about 
enrollment and encouraged to consider enrollment if they have not already.  Nurses at the clinic 
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assisted patients who were interested in enrollment to sign up at the time of their visit or patients 
were provided a code to enroll at their convenience at home.  The code was printed on their 
patient instructions and given to them after the visit. Patients were instructed that communication 
between the staff and patients could occur via secure messaging, blood glucose numbers could 
be entered into the flowsheet tab in MyChart or communicated through secure messaging or 
phone/fax, and explanation was given about lab results and AVS instructions. 
After an account was established, patients could login to the PWP to access various 
information and features including laboratory results, appointment reminders, medication refill 
requests, blood sugar flow sheets, patient instructions, and secure messaging. All communication 
between the patient and provider are stored in the EHR.  The specific features included in this 
study are further discussed in the variables and measurements section. This section does warrant 
discussion on how each PWP feature is utilized in the diabetes and pregnancy clinic. 
Appointment reminders are sent automatically through MyChart for each diabetic visit 
confirming the appointment date, time, location, and any special instructions.  The AVS provides 
patient instructions and medical information to the patient via MyChart after each diabetic visit.  
The AVS for the diabetic visits used a standard template of problem list, allergies, diagnosis, 
medications and treatment team for all patients. In addition, there are patient specific instructions 
and education that are included in the AVS specific to the diabetic patient and that visit which 
may include specific patient goals or dietary instructions and follow-up.  The AVS is typically 3 
pages or longer in length. The lab results section allows patients to review their lab results, 
specifically hemoglobin A1c and glucose tolerance test results as a specific result and trending 
over time.  Medication refills is a request to the provider to refill a prescription which in this case 
would be insulin.  The blood glucose flowsheet was built to have patients submit their blood 
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glucose numbers via MyChart and then be electronically filed. Finally, the secure messaging 
feature allows the patient to communicate with the nurse or provider via MyChart to ask 
questions, send blood glucose information, or seek clarifications.  The workflow in the diabetes 
and pregnancy clinic is to respond to these messages on a daily basis. 
Use of the PWP was in addition to routine care within the clinic. Routine care typically 
consisted of diabetes visits every two weeks with the certified diabetic nurse educator, then 
weekly at 36 weeks and thereafter until delivery unless otherwise specified by the provider.    
All patient level usage of Epic MyChart was timestamped and stored in the 
organization’s server log files. The server files provided time information and frequency of PWP 
use regarding each feature of the PWP for purposes of this study. 
Procedures for Data Collection 
After IRB approval was obtained, a report from the healthcare organization’s data 
warehouse was created by IT analysts of all women who sought care in the diabetes and 
pregnancy clinic between January 2013-January 2016 with a diagnosis of GDM and who met the 
inclusion criteria. The report excluded women who did not meet the inclusion criteria. In 
addition, the IT analysts created a report from the MyChart server log files that provided the 
PWP activity by each woman as defined by the number of hits to a particular feature of the PWP. 
This report was used to separate subjects into three groups- nonusers, short-term users, and 
persistent users.  It also served as the data source for PWP usage. It captured the date and time of 
each activity to a PWP feature by individual over the third trimester of pregnancy.  The usage 
report was exclusive to the PWP activity within the diabetes and pregnancy clinic and the GDM 
diagnosis and not the user’s PWP use in general. The data was then categorized according to the 
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PWP feature accessed, number of hits, and over what period of time to establish the pattern of 
use. The data was then imported into SPSS.  
 A second report was created by an IT analyst from Epic based on the inclusion criteria 
that outlined the patient characteristics per individual.  Target blood glucose levels for each 
woman collected via the PWP, telephone, or office visit, were gathered by the PI via a hospital-
based Excel database.  The percentage of blood glucose levels within target range for each 
woman per month were entered into the SPSS spreadsheet. 
All data was stored on a personal, password protected laptop in a locked office.  The initial 
reports required a patient’s name and MRN number so the PI could match the blood glucose 
levels, PWP activity, and patient characteristics to the correct patient.  Once files were merged, 
the subject was assigned a number and the data became de-identified.  The legend of the patient 
name and assigned number was stored in a separate file outside of SPSS in a locked file cabinet.  
A codebook was developed and stored electronically in SPSS.   
Study Variables and Measurements 
The study variables included measures of (a) patient characteristics, (b) PWP features and 
patterns of use, and (c) targeted blood sugar achievement. 
Patient Characteristics. A set of patient characteristics was collected for all subjects.  
These characteristics were collected at the entry point into the study which was the first visit to 
the diabetes in pregnancy clinic.  Some of the variables, (e.g. race and ethnicity) may have been 
documented in the EHR prior to referral to the clinic, and the most recent entry was used. Age, 
race, ethnicity, marital status, insurance, and employment were abstracted from the 
demographics section of the EHR in the data warehouse.  Clinical data such as BMI, type of 
GDM, and number of pregnancies with GDM, were abstracted from the clinical flowsheets and 
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documentation within the EHR.  More specifically, they were abstracted from the prenatal 
flowsheets at the point of the first diabetes in pregnancy clinic visit. Conceptual and operational 
definitions for each variable are described in Table 4.  
PWP Features.  Since PWPs features are not standardized across institutions, each 
feature was defined and outlined for this study.  The features included for this study were 
patient/provider messaging, flowsheets/blood sugar logs, after visit summaries/ instructions, labs, 
appointment reminders, and medication refills.  Conceptual and operational definitions for each 
of these variables are outlined in Table 4.  
Each feature was analyzed based on the frequency and pattern of use during the third 
trimester of pregnancy.  Access to each feature was reported in whole numbers. The starting 
point was the date of the patient’s first diabetes in pregnancy appointment and terminated at the 
date of delivery.  To expedite the abstraction process a report was created from the MyChart web 
server log files that produced the number of times a PWP feature was accessed, what was 
accessed, and the date/time for each woman during the study period. 
PWP frequency.  The number of times that each patient logged into the PWP and the 
number hits for each feature they used per login session was captured. Frequency of use was 
measured by the number of “hits” or times the patient accessed a feature of the PWP. This may 
include more than one “hit” within the same minute. All “hits” were included in the data.  
For the purposes of this study, the category “ nonusers” applied to subjects who logged in 
only once.  “Short-term users” were women who logged in during the first month after 
enrollment but not thereafter.  “Persistent users” were users that logged in throughout the third 
trimester.  
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PWP patterns of use.  This study also examined user’s patterns of PWP use during the 
third trimester. A “pattern of use” is defined as the utilization of PWP features from first 
appointment in the diabetes in pregnancy clinic to the time of delivery.  It includes frequency and 
consistency of PWP use. Duration of use was unable to be captured.  Frequency of PWP use was 
defined as the  PWP features accessed and the number of hits on each feature over the study 
period. Consistency was measured in hit days and hit months. Hit day was any day that the 
patient accessed the PWP in the third trimester regardless of the number of times accessed that 
day or features accessed. Hit month captured any individual month where the patient accessed 
any feature of the PWP at least once.    
Target blood glucose levels. Target blood glucose levels were measured using the 
percent of blood glucose levels reported each month within target range per subject.  Target 
blood glucose levels were identified as less than 125 mg/dL for fasting and post-meals.  A 
fasting plasma glucose level >126 mg/dl (7.0 mmol/l) or a casual plasma glucose >200 mg/dl 
(11.1 mmol/l) meets the threshold for the diagnosis of diabetes, if confirmed on a subsequent 
day, and precludes the need for any glucose challenge (ADA, 2003). All reported blood glucose 
levels for the month were recorded into a hospital password protected shared folder and then a 
percentage is calculated monthly using the number of blood sugars reported within target range 
divided by the total number of blood glucose levels reported. This process is repeated monthly 
during the third trimester until delivery. 
Plans for Data Analysis  
The data were analyzed using SPSS version 23. To answer aim 1, descriptive statistics were 
performed using a frequency table including mean and standard deviations as well as  
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independent t-tests on the continuous variables of age and pre-pregnancy BMI.  A Pearson’s chi-
square test of independence was performed on all categorical variables using cross tabulation.   
To answer aim 2, categorical variables were expressed as percentages and continuous 
variables as means with standard deviation (SD) and range. A histogram was generated to assess 
distribution, and then skew was calculated (Meyers, Gamst, & Guarino, 2013).  Independent t-
tests were performed for age and pre pregnancy BMI between PWP users and nonusers, and chi 
square tests were conducted on the remaining patient characteristics.  
To answer aim 3, a repeated measures ANOVA was performed to compare glycemic control 
between users and nonusers. Groups included users and nonusers.  The intervention was PWP 
use with the outcome variable being glycemic control. Glycemic control was measured monthly 
over the third trimester.  An F-statistic was calculated and an alpha of 0.05 was used.    
Human Subjects/Institutional Review Board 
Institutional Review Board approval was obtained through the University of Wisconsin-
Milwaukee (UWM).  An application of deferral was completed and granted in September 2016 
from ProHealth Care to defer all IRB activities for this study to UWM. The ProHealth Care 
deferral is located in Appendix A.  The UWM IRB approval can be found in Appendix B.  
Summary of Chapter 
This study used a retrospective cohort design to address the following research aims: 1) 
compare the characteristics of nonusers and users of a patient web portal (PWP) for self-
management including relationships between characteristics and PWP use/nonuse, 2) in users of 
the PWP, describe the frequency and patterns of PWP use and, 3) compare glycemic control 
between PWP users and nonusers.  The data sources for this study included the Epic EHR, 
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MyChart server log files, and a departmental Excel database. Data collection methods are clearly 
outlined along with data analysis techniques to elicit the best outcomes for the study questions.  
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Chapter 4 
Results  
Between January 2013 and January 2016, 181 patients met the inclusion criteria.  Of the 
181 patients, 23  patients were further excluded from the analyses due to lack of data on target 
blood sugars (meaning there were no data for any months within the third trimester) (n=17) or 
they were a duplicate patient (n=6).  Patients with more than one pregnancy during the three year 
study timeframe were included and captured as a separate subject for each pregnancy. In other 
words if a patient had a pregnancy in 2014 and met the inclusion criteria, her data was captured 
for 2014. If she also had a subsequent pregnancy in 2016, and again met the inclusion criteria, 
her 2016 data was captured and analyzed as well but, the data was recorded as a separate 
occurrence. This was the case for 2 records. Of the 158 patients with complete data for analysis, 
6 (4%) were considered short-term users, 85 (54%) were persistent users, and 67 (42%) were 
nonusers. Due to the power analysis discussed in the methods section suggesting the need for a 
minimum of 159 patients with 80 percent power for detecting a medium sized effect with a 0.05 
significance, short-term users and persistent users were combined into a single user group. The 
final groups consisted of 67 (42 %) nonusers and 91 (58%) users.  
Results for Aim 1  
Research aim 1 sought to compare the characteristics of nonusers and users of a patient 
web portal (PWP) for self-management including relationships between characteristics and PWP 
use/nonuse (see Table 5). 
Users of the PWP were more likely to be employed fulltime and this difference was 
statistically significant (p= .011).  Marital status was somewhat similar between the groups with 
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50 (74.6%) of nonusers and 74 (81.3%) of users being married and 28 (17.7%) of nonusers and 
14 (20.9%) of users being single. Similarly, the chi- square test illustrates that there is not a 
statistically significant difference in marital status between users and nonusers of the PWP 
(p=.522). Two categories of marital status, divorced and significant other, had expected counts 
less than five. Legally separated and widowed were zero for both PWP users and nonusers.  
No statistically significant difference existed between users of the PWP and nonusers for 
history of previous pregnancies with GDM (p= .192),  although a greater percentage of users had 
no prior history of GDM in a previous pregnancy (71.1%) versus nonusers (61.2% ).  Similarly, a 
greater percentage of users had diet controlled gestational diabetes [n=76 (83.5%)] than did 
nonusers [n=50 (74.6%)] however; this was not statistically significant (p=.169).  Most patients 
had private insurance with a greater percentage noted in the user group [n=79 (86.8%)] versus 
the nonuser group [n=51 (76.1%)].  Nine (13.4%) of nonusers and five (5.5%) of PWP users did 
not have an insurance type on file.  
This study sample was homogenous in terms of race.  One hundred twenty five of the 158 
subjects (79.1%) noted their race as White/Caucasian with a greater percentage being users of 
the PWP [n=78 (85.7%)] compared to nonusers [n=47 (70.1%)],  (p=.023).  While statistically 
significant, there were numerous expected counts less than five when performing the chi-square 
test. The same holds true for ethnicity (p= < .001).  
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Table 5 
Patient Characteristics of PWP Users and Nonusers for GDM self-management 
 Total 
 
Nonusers 
N=67 
Users 
N=91 
(p-value) 
Age (mean) N=158 31.1 (SD 4.30) 30.5 (SD 4.24) .411 
Race N=158   .023 
White/Caucasian 125 (79.1%) 47(70.1%) 78 (85.7%)  
Black/African American 4 (2.5%) 1(1.5%) 3 (3.3%)  
Asian 16 (10.1%) 8 (11.9%) 8 (8.8%)  
Hispanic 3 (1.9%) 3 (4.5%) 0 (0%)  
Hawaiian/Pacific Islander 0 (0%) 0/0% 0 (0%)  
American Indian/Native 
Alaskan 
0 (0%) 0/0% 0 (0%)  
Other 6 (3.8%) 4 (6.0%) 2 (2.2%)  
Unknown 4 (2.5%) 4 (6.0%) 0 (0%)  
Ethnicity N=158   < .001 
Nonhispanic Latino 137 (86.7%) 49 (73.1%) 88 (96.7%)  
Hispanic/Latino 19 (12.0%) 16 (23.9%) 3 (3.3%)  
Patient chose not to answer 2 (1.3%) 2 (3.0%) 0 (0%)  
Marital Status N=158   .522 
Married 124 (78.5%) 50 (74.6%) 74 (81.3%)  
Single 28 (17.7%) 14 (20.9%) 14 (15.4%)  
Divorced 5 (3.2%) 2 (3.0%) 3 (3.3%)  
Significant Other 1 (0.6%) 1 (1.5%) 0/ 0%  
Legally Separated 0 (0%) 0/0% 0/0%  
Widowed 0 (0%) 0/ 0% 0/ 0%  
Insurance N=158   .164 
Public 14 (8.9%) 7 (10.4%) 7 (7.7%)  
Private 130 (82.3%) 51 (76.1%) 79 (86.8%)  
Not reported 14 (8.9%) 9 (13.4%) 5 (5.5%)  
Employment N= 158   .011 
Fulltime 89 (56.3%) 28 (41.8%) 61 (67.0%)  
Part-time 18 (11.4%) 9 (13.4%) 9 (9.9%)  
Self employed 5 (3.2%) 2 (3.0%) 3 (3.3%)  
Not employed 46 (29.1%) 28 (41.8%) 18 (19.8%)  
Prepregnancy BMI (mean) N=152 28.6 (SD 6.16) 29.6 (SD 6.74) .322 
Type of GDM N=158   .169 
Diet controlled 126 (79.7%) 50 (74.6%) 76 (83.5%)  
Insulin 32 (20.3%) 17 (25.4%) 15 (16.5%)  
Prior pregnancy with GDM N= 157   .192 
No  41 (61.2%) 64 (71.1%)  
Yes  26 (38.8%) 26 (28.9%)  
Note. SD= standard deviation. 
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The histogram examining age in users and nonusers demonstrated a fairly normal 
distribution (see Figure 3). The skewness for nonusers was -.43 and the skewness for users was -
.40 both within the conservative acceptable threshold of +.5 for normality (Meyers et al., 2013). 
The mean age of nonusers (with standard deviations in parentheses) was 31.1 (4.30) and ranged 
from 20 to 42 years. Users of the portal ranged from 18 to 40 years of age with a mean of 30.5 
(4.24).   
Figure 3. Histograms Showing Frequency Count of Age with Normal Curve Superimposed 
among Users and Nonusers of the PWP 
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The mean pre-pregnancy BMI was 28.6 (6.16) for nonusers and 29.6 (6.74) for users. The 
skewness for pre-pregnancy BMI was greater than age for both users and nonusers of the PWP.  
Skewness for nonusers was .542 and .601 for users. Despite this, the histogram displayed a fairly 
normal distribution for pre-pregnancy BMI in both groups (Figure 4). Of note, one missing value 
existed for pre-pregnancy BMI in the nonuser group and five missing values existed in the user 
group.  
Figure 4. Histograms Showing Frequency Count of Pre-pregnancy BMI with Normal Curve 
Superimposed among Users and Nonusers of the PWP 
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An independent t-test was also conducted on the age and pre-pregnancy variables.  For 
both age and pre-pregnancy BMI, the Levene’s test for Equality of Variances p > .05 so the 
equal variances assumed line was utilized for analysis. The results suggest that there was no 
significant difference in age for nonusers (M=31.10, SD= 4.30) and users of the PWP (M=30.54, 
SD= 4.24), t(156)= .82, p= .411. Additionally, there was not a statistically significant difference 
in pre pregnancy BMI between nonusers (M= 28.57, SD= 6.16) and users of the PWP (M= 
29.62, SD= 6.74), t(150)= .993, p =.322  
Table 6 
Independent T-Tests for Age and Pre-pregnancy BMI among PWP Users and Non-users 
                     F      Sig.    t         df    Sig. (two-tailed)   Mean dif.  Std. Error 
            Diff. 
Age at first visit 
Equal variances assumed .003 .954 .824 156    .411  .566  .687 
Equal variances not assumed   .823 141.37     .412  .566  .688 
Pregravid BMI 
Equal variances assumed .250 .618 -.993 150    .322  -1.06  1.06 
Equal variances not assumed   -1.00 145.44    .316  -1.06  1.05 
Note. Sig.= significance; dif.= difference; Std= standard 
Results for Aim 2 
 Aim 2 sought to describe the frequency and patterns of PWP use in users of the PWP. 
The PWP was accessed 4,870 times by the 91 users over the study period from January 2013-
Januray 2016. Descriptive statistics for each PWP feature are reported in Table 7. Three outliers 
were excluded from the analysis, resulting in 88 users. The most commonly used PWP feature 
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was the appointment reminders with a mean of 24.31 (SD 25.05) hits with a broad range from 0 
to 93 hits. Of note, three patients accessed this feature more than 100 times and were excluded 
from the analysis. The after visit summary (AVS) was the second most frequently accessed 
feature during the third trimester of pregnancy with a mean of 15.44 (SD 17.00) ranging from 0 
to 67. One patient was noted to have reviewed the AVS more than 100 times and was excluded 
from the analysis.  Labs, secure patient messaging, and flowsheets were accessed less frequently 
and many people did not access these features at all. No patients utilized the insulin refill feature 
of the PWP (n=15).  
Table 7 
Frequency of Use Related to Specific Features of the PWP 
PWP feature  n Min  Max  Mean  Mode  SD 
Appt reminder  88 0  93  24.31  1  25.05 
AVS   88 0  67  15.44  3  17.00 
Labs   88 0  23  2.47  0  3.36 
Flowsheet  88 0  30  1.31  0  5.02 
Pt message  88 0  11  .35  0  1.46 
Insulin refill  88 0  0  .00  0  .000 
 
Note. Min= minimum; Max= maximum; SD= standard deviation; Pt= patient; Appt= 
appointment; AVS= after visit summary 
Patterns of PWP use were also measured in terms of consistency. Hits were any days that 
the patient accessed the portal regardless of the number of hits within that day.  Hit month was 
any month that the patient accessed the PWP at least once in that month. Again, wide variation 
existed in terms of individual access as noted in Table 8. 
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Table 8 
Consistency of PWP Use among PWP Users 
   Min  Max  Mean  Mode  SD 
Hits/day  1  61  13.60  6  10.16 
Hits/month  1  3  2.76  3  .06 
______________________________________________________________________________
Note: n=91; Min= minimum; Max= maximum; SD= standard deviation  
Duration or length of time spent on each PWP feature was unable to be measured in this study.  
The most common time of day that the PWP was used was between 0801 and 1200, followed by 
1201 and 1600. See Figure 5 for breakdown of PWP access by time of day.  
Figure 5. Frequency of PWP Access Throughout the Day Over the Third Trimester 
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Due to the low usage overall, it was difficult to establish additional patterns of use.  As 
noted earlier, six users only accessed the PWP for the first month. Four users only accessed the 
PWP once after initial log in while one person accessed features within the PWP 319 times. 
Results for Aim 3   
Aim 3 sought to compare glycemic control between PWP users and nonusers. A repeated 
measures ANOVA was conducted to compare the effect of PWP use (IV) on percentage of blood 
glucose levels at month one, two, and three of the third trimester of pregnancy (DV).  Target 
blood glucose levels were measured as the percentage of reported blood sugars per subject that 
was less than 125 mg/dL each month. The mean target blood glucose levels for nonusers of the 
PWP was similar to that of users however; users of the PWP continued to see improvement over 
all three months of the last trimester. Descriptive statistics for users and nonusers of the PWP are 
outlined in Table 9. 
Table 9 
Descriptive Statistics for Target Blood Glucose Levels among PWP Users and Nonusers 
  Month  Mean  Min  Max  SD 
Nonusers 1  76.0  23  100  17.4 
  2  84.1  30  99  13.6 
  3  82.8  27  100  13.9 
Users  1  79.1  21  100  17.9 
  2  83.0  29  100  13.8 
  3  84.4  25  100  15.2 
Note: Min=minimum; Max= maximum; SD= standard deviation 
59 
 A Mauchly’s Test for Sphericity was performed. This test assesses for the assumptions that 
the levels of within-subjects variable display equal variances and the variances are the same at each 
point (Meyers et al., 2013).  The Mauchly’s Test of Sphericity indicated that the assumption of 
sphericity was violated, [X2 (2) = 47.494, p < .001] therefore, the Greenhouse-Geisser correction was 
used to generate sphericity-corrected F ratios.  The Greenhouse-Geisser correction in the Tests of 
Within-Subjects Effects determined that the percentage of blood glucose levels within target range 
differed significantly over the three months (F (1.520, 191.474) = 1946.330, p=  < .001) but did not 
differ significantly between PWP users and nonusers (F (1.520, 191.474) = 184.428, p=.559) .  The 
between groups test also indicates that there was not a statistically significant difference between 
PWP users and nonusers. The estimated marginal means graph (Figure 6) illustrates the 
improvement of target blood glucose levels in both PWP users and nonusers over time. There 
was a small decrease in target levels in the third month for nonusers that were not apparent in the 
PWP user group. 
Figure 6. Estimated Marginal Means for Target Blood Glucose Between PWP Users and 
Nonusers 
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Note. Tbs= target blood sugars (blood glucose levels); Month= month 1, 2,3 of third trimester. 
Target blood glucose levels were measured as the percentage of reported blood sugars per 
subject that was less than 125 mg/dL each month . 
Chapter Summary 
Data analysis was performed on a total of 158 women. This number was insufficient to 
divide the sample into the original three groups of nonusers, short-term users, and persistent 
users. As a result, short-term users and persistent users were combined into one group which 
resulted in 91 users and 67 nonusers.  There were no statistically significant differences between 
PWP users and nonusers for age, pre pregnancy BMI, marital status, insurance, history of 
previous pregnancy with GDM, or type of GDM. A significant difference was noted for race and 
ethnicity but skewed by the numerous expected counts less than five in the analysis. There was a 
statistically significant difference between employment status among PWP users and nonusers 
with PWP users more likely to be employed fulltime and nonusers more likely to not be 
employed.  
Users of the PWP tended to access the portal each month in the third trimester.  However, 
consistency on the number of individual days in which the PWP was accessed varied greatly 
with the greatest number of patients accessing the PWP on six individual days throughout the 
third trimester. PWP users accessed the portal most frequently during the day between 0800-
1200 and 1200-1600. The most frequently accessed features within the PWP were the AVS and 
appointment reminders. Finally, the percentage of blood glucose levels within target range differed 
significantly over the three months but did not differ significantly between PWP users and nonusers. 
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Chapter 5 
                                                         Discussion 
Patient web portals are increasingly being used to assist with diabetes self-management 
and have become a focus for meaningful use incentives and engaging patients in their care. 
Limited research exists on the use of PWPs for GDM self-management. This study attempted to 
address this gap by describing the patient characteristics of users and nonusers of a GDM PWP, 
explore patterns of PWP use, and determine relationships between PWP use and glycemic 
control.  
Patterns of Use 
Patterns of use were measured through frequency, consistency of use, and time of day.  
As noted in the results section, the PWP features were accessed 4,870 from January 2103-
January 2016 among 91 patients. There appears to be a wide range of use among the various 
features of the PWP with appointment reminders being the most frequently accessed followed by 
the AVS.  Medication refills were not accessed at any point by any patient in this study.  
Although the majority of patients in the study were diet controlled, there were still 15 women on 
insulin who used the PWP, yet none of them requested a medication refill through the PWP. A 
plausible reason for this is the short duration in which insulin is prescribed. A patient may not 
need to request a medication refill if the original prescription was dispensed in an amount that 
could last three months by which point she gave birth and the GDM resolved. 
  Secure messaging was also used infrequently, which is incongruent with other studies. 
In fact, secure messaging and prescription refill requests are the most commonly accessed PWP 
features in many studies (Halamka et al., 2008; Silvestre, Sue, and Allen, 2009; Yamin et al., 
2011).  A possible reason for the decreased use of secure messaging in this study may be the 
frequent appointments that are involved with managing GDM.  If questions are answered during 
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the appointment visit, there may be less reason to use secure messaging. That being said, 
frequent communication of blood glucose levels between the patient and diabetic educator is 
necessary to promote optimal blood glucose control and decrease maternal-fetal complications.. 
Secure messaging could be one method of this communication. 
The consistency of PWP use showed most patients accessed the PWP over all three 
months in the third trimester. Variation existed among patients in terms of the number of 
individual days they accessed the PWP ranging from 1 to 61 days. Most patients accessed the 
PWP a total of six days throughout the third trimester. Other studies on PWP use in this 
population have not reported on this, which offers new insight into PWP use for patients with 
GDM.   It appears that women with GDM who use the PWP do so over the course of the third 
trimester, which suggests that PWPs may provide health care providers with an opportunity to 
target information throughout the last three months of pregnancy to optimize blood glucose 
levels.  
PWP Use and Glycemic Control 
While there was not a statistically significant difference in target blood glucose levels 
between PWP users and nonusers, the findings do illustrate improvements in target blood 
glucose levels in both groups over time. This would be expected given a well-established current 
educational program and frequent provider contact to assist with GDM management for pregnant 
women. Studies conducted in Australia and the United States demonstrated fewer perinatal 
complications, lower birthweights, and less preeclampsia in women who engaged in counseling 
and treatment programs specific to GDM (Crowther et al., 2005; Landon et al., 2009).  
Interestingly, the nonusers only saw the improvement in the third trimester from month 
one to month two and then had a slight decline in month three. Moreover, the target blood 
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glucose levels of PWP users improved steadily over the three months, beginning in month one 
with a higher blood glucose percentage and ending with a higher blood glucose percentage in 
month three than  nonusers. These differences cannot be directly attributed to PWP use, but 
suggests that further investigation into these differences should occur.  
Patient Characteristics  
Except on the variable of employment, users and nonusers of the PWP did not display 
significant differences in terms of patient characteristics. There was a statistically significant 
difference in employment status between users and nonusers of the PWP; however; the results 
should be interpreted cautiously, since some of the categories of patient characteristics had fewer 
than 5 responses.  Users were more likely to be employed fulltime. These results support a 
previous Italian study conducted by Scailoli and colleagues (2015) whereby pregnant women 
who were employed more often used the internet for health related information pertinent to 
pregnancy. In addition, these findings align with Kaptein and associates (2014) who concluded 
women with GDM desired education and care that minimized travel and time commitments. 
Similarly, Parson and colleagues (2014) identified several barriers to GDM management that are 
relevant to fulltime employment including lack of time, lack of clear and timely information, and 
lack of interventions that fit into women’s multiple roles as caregivers, workers, and patients.   
Fulltime employees may find PWPs as a means to overcome some of these barriers. The PWP 
was most frequently accessed between the hours of 0800-1200. These results may speak to the 
accessibility of the PWP at a time when many people are at work. 
 Users and nonusers of the PWP primarily identified themselves as non-Hispanic white. 
The results of this study do not suggest a significant difference in insurance type among users 
and nonusers of the PWP.  These findings are incongruent with some of the literature that 
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suggests a “digital divide” exists among users and nonusers of PWPs. Previous studies by Laz 
and Bereson (2012) and Yamin et al. (2011) found a significant difference between PWP 
adoption rates with white patients adopting the PWP and internet significantly more than other 
racial and ethnic groups.  Future analysis using a larger sample size should be conducted to 
validate the findings of this study for women with GDM.  
Pertinent clinical related history did not appear to play a role in PWP use.  Pre-pregnancy 
BMIs were fairly consistent among the user and nonuser groups as was the type of GDM.  This 
was similar to findings in a study by Jones et al. (2015) regarding PWP use in 2,282 patients with 
cardiovascular disease and/or diabetes who sought care at Geisinger’s primary care clinics. The 
mean BMI was 31.36 in the nonuser group and 31.34 in the user group. The Jones et al. study did 
not outline diabetes type in their results.  
The results of this author’s study mirror. the total sample with more women diagnosed 
with diet controlled GDM than insulin for both the user group and nonuser group.  Interestingly, 
slightly more insulin controlled GDM women were nonusers of the PWP than users of the portal.  
This may be due to the medical complexity of insulin management which at times requires more 
clinical appointments. Other studies have found that patients with more complex conditions or 
multiple co-morbidities have more frequent clinical appointments and less PWP adoption 
(Yamin et al., 2011).  
 Nonusers of the PWP may more often be women with insulin dependent GDM due to 
perceived lack of functionality or preferences in the existing PWP. A study by Ronda and 
colleagues (2015) found that insulin dependent diabetes patients wanted functionalities in the 
PWP such as the ability to add their injected insulin doses to the electronic diary and receive 
educational updates. The authors concluded that one uniform PWP may not be suitable for all 
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diabetes patients; rather designing separate PWPs for different types of diabetes may be more 
successful.  A follow-up study of women with GDM could be conducted to determine frequency 
of visits with patient’s attitudes or values of the PWP. Furthermore, a future study could  
qualitatively explore the perceived barriers of PWP use for patients with insulin controlled 
GDM.  
It was thought that women with no previous history of GDM would perhaps use the PWP 
more than women who had a previous pregnancy with GDM.  While more women without a 
history of GDM did use the PWP, the difference was not statistically significant.  
Limitations 
There were several limitations to this study. A common problem with retrospective 
designs is the sample size. In an effort to capture enough patients, a power analysis was 
conducted. Unfortunately, the numbers fell short to divide the groups into the original three 
groupings of nonusers, short-term users, and persistent users resulting in the consolidation of 
short-term users and users into one group.  
Another limitation of this study was the unmeasured provider and clinic level behaviors 
that may have influenced the patient’s use of the PWP. For example, this study did not measure 
the provider or RN preferences for the PWP, nor whether or not their preference affected the 
patient’s use or nonuse of the PWP. Furthermore, specific clinic practices such as reminder 
phone calls for appointments and response time to secure messages were also not captured in this 
study.  Previous research has suggested that provider and clinician preferences can greatly 
influence adoption of patient PWP use (Izarry et al., 2015; Logue & Effken, 2012).  Future 
studies should capture these variables on this specific population.  
This study also is limited to one Internet portal used within one organization therefore; 
the results may not be generalizable to other portals, patients, or health care systems (Polit & 
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Beck, 2012).   This is notable given the wide variation and lack of standardization on the core 
elements of each PWP.  This particular study encompassed the following PWP features: secure 
messaging, appointment reminders, AVS, lab results, flowsheets, and medication refills.  Other 
studies on PWPs may include other features thus, generalizability is limited. The author 
acknowledges that the lack of standard definitions for users and nonusers of PWPs complicates 
the overall generalizability of the results. Definitions for users and nonusers were defined for this 
study however, vary immensely in the literature.   
Finally, the inability to capture time spent in each feature of the PWP was a major 
limitation to this study.  Number of log-ins or hits within a particular feature of the PWP does 
not capture the actual time spent within each feature of the PWP. Many PWP studies exist 
whereby usage is measured by the number of log-ins and hits to individual features of the PWP, 
but greater clarity is found when both the frequency and duration of PWP use is measured. In 
fact, a study by Jones et al. (2015) measured PWP usage by frequency, consistency, intensity, 
and duration of PWP use to outline user phenotypes and distinct patterns of use. The authors 
claim that amount of use/frequency captures just one domain of effective PWP use (Jones et al.).  
The Jones et al. study was the basis for the operational definitions of this study. 
Significance 
Practice 
Nurses play an important role in the promotion and sustainability of PWP use and are 
often the gateway to patient enrollment (IOM, 2010; Logue & Effken, 2012; Seckman, 2014).  
Nurses are also patient educators  and themselves, are one of the largest groups of EHR users 
within a healthcare system making it critical that nurses have adequate knowledge of PWP 
features and offer insight into future design development (IOM, 2010).   
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This study informs nursing practice in several ways.  First, it provides insight into the 
patient characteristics of users and nonusers of a PWP for GDM self-management.  Scant 
research exists on this type of technology for GDM management much less the patient 
characteristics of these women (Carolan et al., 2015; Osborn, Mayberry, Mulvaney, & Hess, 
2010). Understanding the patient differences between users and nonusers of the PWP is key to 
overcoming barriers to PWP use and instrumental in the design of future PWP enhancements for 
individual preferences. For instance, fulltime employment may be a motivator for PWP use. 
Future enhancements to the PWP should engage employed patients in the development and 
usability testing prior to implementation. Equally important, is to explore the barriers to PWP 
utilization for women who are not employed.   
Furthermore, this study highlights some patterns of PWP use.  Appointment reminders 
and the AVS were the most frequently accessed features of the PWP.  Women who frequently 
accessed the appointment reminders could potentially respond positively to completing activities 
prior to a clinic visit. Examples of such activities include completing health questionnaires, 
goals, or administrative forms. Completion of these activities prior to the visit could save time 
during the actual appointment.   
Women who frequently accessed the AVS may respond to additional factual information 
or resources regarding GDM.  This may include links to credible websites and/or specific 
information embedded in the document.  Prior studies suggest that between 70 to 90 percent of 
pregnant women are e-health users and 83 percent used the internet to influence a pregnancy 
related decision (Lagan, Sinclair, & Kernohan, 2010; Narasimhulu, Karakash, Weedon, & 
Minkoff, 2016).  As primary educators to patients, nurses have an opportunity to provide 
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accurate, credible resources to patients through the AVS, which remains accessible to the patient 
throughout the pregnancy.   
The PWP may serve as a repository for  trusted and credible patient education resources 
or website links related to GDM management that are accessible to patients.  Specifically, the 
PWP could provide nutrition details perhaps including carbohydrate counting guidelines and 
links to food/carbohydrate calculators. Exercise guidelines could also be outlined in the PWP.  
Previous research indicates that effective GDM management programs and interventions should 
include the three categories: (1) self-monitoring of blood glucose levels, (2) dietary and exercise 
interventions, and (3) behavioral interventions/counseling (Brankston et al., 2004; Carolan, 2015, 
Hopichler & Lechleitner, 2001, Landon et al., 2009; Moses et al., 2009). Certainly, if the intent 
of a GDM PWP is to improve maternal, fetal, and neonatal outcomes, the PWP itself should 
incorporate these three categories.  The results of this PWP study suggest the Carolan (2015) 
framework was not used when developing and implementing the PWP however; suggestions on how 
incorporate its categories are discussed above. 
Another key finding in this study was the consistency of PWP use among users. Users of 
the PWP tended to access the PWP over the full third trimester.  This is valuable information as 
it provides an avenue for ongoing self-management possibilities.  Certain strategies could be 
delivered at set time periods throughout the third trimester. For instance, currently patients are 
provided with a diabetes educational folder at their first visit which is reviewed between the 
patient and certified diabetic nurse educator. If PWP users tend to access the PWP throughout the 
third trimester, relevant information could be re-sent or reviewed with patients in different time 
increments to encourage sustained engagement with the PWP.  
It is surprising that secure messaging and medication refills were so underutilized given 
most prior research finds these features to be the heavily utilized (Halamka et al., 2008; Silvestre 
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et al., 2009; Yamin et al., 2011). As discussed previously, a plausible reason for the lack of 
medication refill requests could be the short time period in which the women are taking insulin.  
If the initial prescription for insulin was issued in the third trimester and refills were issued for 
three or more months, there would be no reason for the patient to request a refill.  This 
explanation was not validated in this study, but warrants further follow-up.  
The infrequent use of secure messaging requires more investigation.  Specifically, it is 
important that barriers and motivators to secured messaging are further explored. Nurses have 
the ability to influence this practice by supporting its use through their own practice and 
informing patients of these features. Moreover, nurses can explore other potential barriers to 
using any of the PWP features including usability and timeliness of communication and devise 
strategies to overcome the barriers.  
Theory 
The use of the Individual and Family Self-Management Theory (IFSMT) guided this 
study (Ryan & Sawin, 2009).  This study evaluated the current use of a particular organization’s 
PWP for GDM self-management and did not test the IFSMT directly.  Part of the reason for 
choosing the IFSMT as the guiding framework was its prior use in studies related to health 
promotion and more acute conditions (Doering, 2013; NIH reporter).  The PWP in this study was 
the intervention that had the potential to influence the process of self-management and impact 
the distal outcome of glucose levels. Unfortunately, time spent on each feature of the PWP could 
not be measured in this study therefore; a connection between PWP use and self-management 
behaviors could not be investigated or validated.  
This study does address several dimensions of the IFSMT. This study unveils the patient 
characteristics of users and nonusers of a PWP for GDM self-management incorporating the 
context domain of the IFSMT.  White race, private insurance, and fulltime employment may be 
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viewed as protective factors for women with GDM to engage in PWP use. This study informs the 
process domain of the IFSMT by introducing a novel technology tool to promote self-
management.  Patients engaged most in the concepts of knowledge and beliefs by frequently 
accessing the AVS and social facilitation by reviewing appointment reminders.  While the study 
results do not suggest a statistically significant difference in target blood glucose levels (distal 
outcome) over the third trimester, they do illustrate continuous improvement over the three 
months unlike the nonuser group. This suggests engagement of the self-management process on 
some level. Future research should measure the dosage of PWP use in terms of length of time to 
determine if patients are utilizing this tool for self-management guidance.   
Due to the low overall PWP use, it is worth taking a step back.  This study evaluated a 
current PWP already in production. It may be advantageous to supplement this study with 
usability testing and utilize a more technology based model before future evaluation should be 
performed on PWP use for GDM self-management. Usability studies enable PWP designers to 
understand the needs of the users and address barriers to improve utilization and effectiveness     
Britto, Jimison, Munafo, Wissman, Rogers, et al., 2009). To the best of this author’s knowledge 
no usability testing was conducted for the GDM PWP nor was a framework used.  The 
Technology Acceptance Model (TAM) was created by Davis and explains computer usage 
behavior including the cognitive and affective determinants of computer acceptance (Davis, 
Bagozzi, & Warshaw, 1989).  The TAM postulates that behavioral intention to use computer 
technology is influenced by external variables, perceived usefulness, and perceived ease of use. 
This model could be the theoretical framework for a future usability study with this PWP for 
GDM patients.  
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Health Policy 
This study could inform improvements in local policy.  The healthcare system from 
which the study sample was pulled is committed to the use of PWPs for its patients and has 
already adopted several practices to increase enrollment.  Enrollment with a PWP does not 
always equate to ongoing use and additional strategies should be instituted to promote sustained 
use of the PWP among its users.  Beyond the enrollment information, nurses and other clinicians 
should provide patient information on the features of the PWP and how they relate to their 
patient/provider interactions.  This also means that nurses need to be knowledgeable on the 
components of the PWP which may require additional and ongoing training for them as well.  
The development and use of PWPs have primarily been promoted for chronic conditions 
within the primary care setting since this is where much of the meaningful use financial 
incentives reside for providers and healthcare organizations.  However, PWP use has been 
expanding into certain specialty areas without much modification to its original format. The idea 
of “build it and they will come” is not evidenced-based and should not be utilized.  
Administrators and clinical staff should explore patient differences and preferences based on 
clinical conditions and modify the PWP accordingly. Usability assessments and testing should be 
standard when developing and implementing any PWP in any organization. Modifications should 
be made based on patient and provider feedback prior to implementation.  This study provides 
insight into the current use for the GDM population and begins to suggest opportunities for 
improvement.  
This study also lends itself to a further evaluation of clinician and provider workflow. 
Administrators and clinicians alike should appreciate the required changes in outpatient 
workflow as compared to in-person visits.  Izarry et al. (2015) point to the difficulty of 
coordinating PWP management tools with current provider/clinician workflow and priorities 
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suggesting that a greater understanding of the adjustments is needed and may require changes in 
current roles and responsibilities. A clinician or provider’s work day no longer consists of a 
patient schedule with a set number of patients to see in person. It has evolved to be a multi-
faceted plan of in-person visits, email messages, prescription refills, results review, and other 
communication that needs to be coordinated amongst various members of the healthcare team. 
Ultimately the adoption of PWPs in any setting, for the population of women with GDM, 
or another population, will require time and resources to thoroughly assess the needs of the 
patient population, the features needed, the readiness for adoption, usability testing, and ongoing 
modifications.  This study offers some beginning insights into the characteristics and patterns of 
PWP use among current users. Opportunities exist for modifications, enhancements, and 
usability testing.  
On a more global level, this study contributed to the body of research on PWP use 
beyond chronic conditions and primary care. As meaningful use expands it is important to take a 
proactive approach to PWP application beyond chronic care and make modifications that are 
specific for that patient population.  
Research 
Since scant research exists on PWPs for GDM management, this study provides just a 
glimpse into this subject for a particular healthcare system and offers ample future research 
possibilities. It is suggested that this study be replicated in other systems with the same or similar 
PWP features and measure patterns of use as defined by frequency, intensity, consistency, and 
duration as described by Jones et al. (2015).  
Additional research could also explore other outcomes beyond glucose levels.  Studies of 
PWP use among men and women with diabetes have demonstrated positive effects on diabetes 
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distress scores with PWP use (Fonda et al., 2009). For example, and initial  study could be 
conducted to validate the Diabetes Distress Screening Scale or similar scale on the GDM 
population. Then, another study could determine if a relationship exists between PWP use and 
diabetes distress.  There are additional possibilities to examine medication adherence in this 
population of patients. Although insulin use is less frequent than diet management for GDM 
control, it is worth investigating whether there is greater medication adherence among women 
with GDM who use a PWP.  A study by Kim and colleagues (2006) concluded that PWP users 
diagnosed with diabetes had greater medication adherence than nonusers of the PWP.however, 
given the study is almost a decade old and the additional features of PWPs, this study should be 
replicated.  
Several opportunities also exist for future qualitative studies.  One of great importance is 
to explore the barriers of using a PWP for GDM self-management particularly for features such 
as secure messaging and medication refills. Beyond the barriers, virtually nothing is known 
about what functionality or enhancements users are looking for within a PWP that would 
promote GDM self-management or the usability of the current PWP. Other research results have 
demonstrated the benefits of early usability testing and patient portal design (Izarry et al., 2015). 
Usability testing was not conducted for this organization’s PWP specific to GDM management.  
Finally, provider preferences, workflow, and barriers should be explored.   
Conclusions 
The following conclusion can be made based on the results of this study: 
1. Appointment reminders were the most frequently accessed PWP feature.  
2. The AVS was the second most commonly accessed PWP feature. 
3. Medication refills were not accessed at all by any patient in the study. 
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4. PWP users most often accessed the PWP each month in the third trimester. 
5. The PWP was most frequently accessed between the hours of 0800-1200. 
6. PWP users tended to be employed fulltime. 
7. PWP users saw improvements in target blood glucose levels in each of the three 
months in the third trimester. 
An assumption cannot be made that improvement in target blood glucose levels is 
directly correlated with PWP use. Furthermore, healthcare delivery factors such as PWP usability 
and provider/clinician endorsement was not measured in this study, but does contribute to 
patient’s adoption of the PWP as noted in previous studies (Logue & Effken, 2012; Wald et al., 
2010).  It is clear that with the continued CMS and Medicaid incentives for meaningful use, 
PWPs will continue to evolve and should be evaluated for their effectiveness. Future research 
should aim to determine barriers and facilitators to PWP use for GDM self-management, conduct 
usability testing on existing PWPs, and determine which, if any, features of the PWP and length 
of time contribute to GDM self-management. . Finally, future studies should not negate 
nonusers. It is equally important to understand the self-management activities of this group of 
women as they navigate through their pregnancy with GDM. Healthcare systems should not view 
PWPs as a panacea, especially for populations of people that may eschew technology for cultural 
or other beliefs.  
The emergence of health information technology (HIT) and PWPs has created new 
opportunities for patient involvement in their healthcare. This technology can only be successful 
with the input of patients and the acceptance and adoption of clinicians and providers. It is clear 
that future research is needed in order to fully implement a patient-centered PWP that optimizes 
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technological capabilities while addressing barriers to its use. Specific user characteristics and 
needs should be addressed. Specific features of PWP should be studied and outcomes measured.  
Chapter Summary 
The findings of the study were discussed and connections to existing literature outlined. 
Limitations of the study were clearly reviewed. Significance to practice, theory, policy, and 
research were discussed in addition to overall conclusions that can be drawn from this study. 
Finally, future research recommendations were suggested. 
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Figure 1.  A mapping of study variables using the Individual and 
Family Self-Management Theory 
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Figure 2. Conceptual Model using the Individual and Family Self-Management Theory 
  
Figure 2. Conceptual model for study adapted from the IFSMT of Ryan and Sawin (2009).  
Variables of the study are listed according to the IFSMT dimensions: Context, Process, and  
Distal Outcome. 
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Table 1 
Context Dimension Variables 
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Table 2 
Process/Outcome Dimension Variables 
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Author/year Study 
design/level 
of evidence* 
Duration 
of Study 
Subjects Intervention/Control 
groups (if applicable) 
Measures   Outcomes/Results 
Fonda et al./ 
2009 
RCT 
 
Level II 
12 months N= 102 
N= 52 intervention, 
N=52 control 
Type 1 and Type 2 
DM 
 
USA 
Intervention: Internet-
based care management 
(MyCare Team website, 
glucose and BP readers) 
 
Control: Usual care 
Diabetes distress 
 
HbA1c levels 
Decreases in HbA1c and diabetes 
distress based on level of usage. 
 
Distress scores lower among users 
than nonusers 
 
Grant et al. 
/2008 
Cluster 
randomized 
control trial 
 
Level II 
12 months N= 126 
intervention group 
 
N= 118 control 
group 
Type 2 DM 
 
11 primary care 
clinics in 
Massachusetts 
Intervention: access to 
DM specific application 
with medication 
management, view of 
current treatment, BP, & 
preventive care 
 
Control: usual care 
HbA1c levels, BP, 
lipid levels 
Decreased rate of primary care visits 
 
Decrease in HbA1c level after 1 yr 
(0.16% vs. 0.26%, p=0.62) 
 
Slight improvement in BP  & lipids 
after 1 yr (not significant) 
 
Medication adjustment for 
hyperglycemia (29% vs. 15%, p=0.1). 
 
Medication adjustment for 
hyperlipidemia (11% vs. 0%, p=0.03) 
Holbrook et 
al./ 2009 
RCT 
 
Level II 
5 months N=511 
Type 2 DM 
 
Primary care 
setting 
 
Canada 
Intervention: web-based 
color-coded diabetes 
tracker and messaging 
 
Control: Usual care 
Continuity of care 
 
Quality of life 
satisfaction 
 
Clinical and process 
composite scores 
Process composite score significantly 
better in intervention vs. control 
(difference 1.27, p<0.001) 
 
Intervention group vs. control had 
improvement (difference 19.1%, 
p<0.001) 
 
Clinical composite score significantly 
better in intervention vs. control (0.59, 
p=0.02) 
 
Intervention group reported greater 
satisfaction with diabetes care 
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Author/year 
 
 
 
 
Study 
design/level 
of evidence* 
Duration 
of Study 
Subjects Intervention/Control 
groups (if applicable) 
Measures Outcomes/Results 
Kim et al./ 
2006 
Pre-post  
 
Level IV 
3 months N=45 
Type 2 DM 
 
Korea 
Intervention: short 
message by cell phone 
and internet web portal 
 
No control 
HbA1c levels, 30 
min. exercise 
(days/week), 
adherence to 
medication 
(days/week), & foot 
care (days/week) 
HbA1c  difference -1.1% + 2.1 
(p<0.006) 
Exercise difference: 0.9 + 2.0 
days/week (p<0.036) 
Medication adherence difference: 1.1 
+ 1.9 days/week (p<0.032) 
Foot care difference: 1.1 + 2.2 
days/week (p<0.030) 
 
 
McCarrier et 
al./2009 
Pilot, RCT 
Level II 
12 months N= 77 
29-49 years old 
Type 1 diabetes 
Last HgA1c level 
>7.0% 
 
Seattle, WA 
Intervention: usual care 
plus the nurse-
practitioner-aided Web-
based case management 
program  
Control: usual clinic care 
 
HgA1c 
Self-efficacy 
intervention group had decrease in 
HgA1C test values of 0.37%, control 
group had slight increase of 0.11%. 
(difference of -0.48% was not 
significant) 
beneficial treatment effect on self-
efficacy 
 
McMahon et 
al./ 2005 
RCT 
 
Level II 
12 months N=104 
 
Type 1 and Type 2 
DM 
 
USA 
Intervention: diabetes 
education class + web-
based care management 
(glucose, BP monitoring 
devices, & website) 
 
Control: usual care of 
diabetes education class 
HbA1c levels 
BP 
HDL 
LDL 
Triglycerides 
HbA1c levels -1.2 in control vs. -1.6% 
in intervention group (p<0.05) 
 
BP levels significantly decreased in 
intervention group (-10 + 17) vs. 
control (-7 +21 mmHg) p<0.01 
 
LDL change- not significant, HDL 
levels increased in intervention group 
(3 + 6 mg/dl) vs. control (1 +6 mg/dl) 
p<0.05. Triglycerides significantly 
decreased in intervention group (-38 + 
99 mg/dl) vs. control (-2 + 60 mg/dl) 
p<0.01 
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Author/year 
 
 
Study 
design/level 
of evidence* 
Duration 
of Study 
Subjects Intervention/Control 
groups (if applicable) 
Measures Outcomes/Results 
Noel et al. 
/2004 
RCT 
 
Level II 
12 months N=104 
Single co-morbid 
diagnoses: heart 
failure, chronic 
lung disease, 
diabetes 
 
USA 
Intervention: home 
telehealth (electronic 
monitoring and alert 
system) + nurse case 
management 
 
Control: Usual home 
health care + nurse case 
management 
HbA1c levels 
 
Quality of Life 
(cognitive status, 
functional level, 
patient satisfaction, 
self-rated health) 
 
Urgent & total visits 
HbA1c  levels: +0.8% in control vs. -
1% in intervention (p<0.01) 
Cognitive status: 19.4 in control vs. 
20.0 in intervention (p<0.01) 
Urgent visits: +5 in control vs. -83 in 
intervention group (p<0.05) 
Functional level, pat. satisfaction, self-
rate health, & total visits- not 
significant 
 
 
Osborn et 
al./2013 
 
Mixed 
methods 
study, cross-
sectional 
design 
 
Level IV 
Not 
defined 
75 adults with 
Type 2 DM 
receiving 
medications  
 
English speaking 
 
Recruited from 
VUMC primary 
care clinics in 
Nashville, TN 
Focus groups, surveys, 
and medical chart review 
Use of portal 
 
Methods portal users 
use to manage their 
medication 
 
Ideas to improve 
functionality of portal 
Portal users more likely to be White, 
have higher incomes, & have private 
insurance 
 
More frequent use of portal was 
associated with better A1C (Spearman 
rho= - 0.30, p=.02) 
 
Suggestions to improve functionality- 
link to pharmacy, deliver med 
information in a user-friendly format 
 
 
 
 
Osborn et 
al./2010 
Systematic 
review 
Studies 
published 
from1/200
0-2010 
26 articles 
reviewed 
Type 1 or Type 2 
diabetes 
Impact of diabetes 
interventions using PWP 
on improving self-care 
behaviors, glycemic 
control, and health 
outcomes 
Self-care behaviors, 
glycemic control, 
health outcomes 
PWP-delivered interventions: 
Enhance patient-provider 
communication, expand access to 
health information, improve disease 
management and patient outcomes 
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Abbreviations Used in Evidence Table 
&: and BMI: body mass index BP: blood pressure btwn: between difft: different DM: diabetes mellitus   DUMC: Duke University Medical Center ER: emergency room 
govt: government   HbA1c: hemoglobin A1c HDL:  high-density lipoprotein LDL: low-density lipoprotein mg/dl: milligrams per deciliter  
MHAV: MyHealthAtVanderbilt mmHg: millimeters of mercury min: minutes N: number PCP: primary care provider pts: patients PWP- patient web portal RCT: randomized 
control trial SES: socioeconomic status vs: versus VUMC: Vanderbilt University Medical Center yr: year 
Author/year 
 
 
Study 
design/level 
of evidence* 
Duration 
of Study 
Subjects Intervention/Control 
groups (if applicable) 
Measures Outcomes/Results 
Ralston et 
al./2009 
Pilot RCT 
 
Level II 
12 months N= 83 
18 to 75 years old 
with type 2 
diabetes 
 
HgA1c  in the prior 
12 months was 
≥7% 
 
Seattle, WA 
Intervention: access to 
electronic medical 
records, secure e-mail 
with providers, feedback 
on blood glucose 
readings, education, and 
an interactive online 
diary  
 
Control: usual care 
HgA1c 
BP 
Total cholesterol 
 
 
HgA1c  levels declined by 0.7% (95% 
CI 0.2−1.3) on average among 
intervention patients compared with 
usual-care patients.  
Systolic blood pressure, diastolic 
blood pressure, total cholesterol 
levels, and use of in-person health 
care services did not differ between 
the two groups. 
Shaw & 
Ferranti/2011 
Cross-
sectional 
secondary 
analysis 
 
Level IV 
5 months All patients with 
Type 1 or Type 2 
DM and enrolled in 
a provider-centered 
decision support 
tool included 
 
From DUMC 
Portal users n= 
5,937, nonusers n= 
14,085 
N/A % of diabetes patients 
that use a portal 
 
HbA1c levels 
Lipid levels 
29.7% of patients with diabetes use 
the portal 
 
Portal use was a significant predictor 
of HbA1c (p< .0001) 
 
Portal use not a significant predictor 
of LDL and total cholesterol levels 
 
Smith et al./ 
2004 
Pre-post test 
 
Level IV 
9 months N=16 
Type 1 and Type 2 
DM 
 
USA 
Intervention: 
MyCareTeam program- 
web-based diabetes 
management program. 
Pts entered blood 
glucose levels, exercise 
log, and got messages 
No control 
HbA1c levels, BP, 
HDL, LDL, 
triglycerides 
HbA1c levels -2.2% (p<0.0001) 
reduction in heavy users 
 
BP, HDL, LDL, & triglycerides- not 
significant 
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Table 4.  
Conceptual and Operational Definitions of Study Variable 
Variable Conceptual Definition Operational Definition Response Type 
CHARACTERISTICS 
Age the number of years since 
a person's date of birth.   
Self-reported number 
of years since the 
person’s date of birth. 
Reported in a whole 
number over the age 
17. 
18-100 
Race Category of humankind 
that share distinctive 
physical traits (Merriam-
Webster dictionary) 
Self-reported race 
according to the choices 
outlined by the Office of 
Management and 
Budget with the U.S. 
government 
 
American 
Indian/Alaska Native 
Asian 
Black or African 
American 
Native Hawaiian or 
Pacific Islander 
White/Caucasian 
Other 
Unknown 
Patient refused 
 
Ethnicity Ethnic quality or affiliation 
(Merriam-Webster 
dictionary) 
Self-reported ethnicity 
according to the choices 
outlines by the Office of 
Management and 
Budget with the U.S. 
government 
Hispanic/Latino 
NonHispanic Latino 
Patient refused 
Unknown 
Marital Status The condition of being 
married or unmarried 
Self-reported marital 
status according to the 
EHR provided choices  
Divorced 
Legally separated  
Married 
Significant Other 
Single 
Widowed 
Unknown 
Insurance Private insurance is 
coverage obtained 
through an employer, 
union, or individual 
purchase. Public insurance 
is Medicaid, Medicare, 
other government-
sponsored programs, or a 
military health plan 
(TRICARE, VA, or CHAMP-
VA). Adults covered by 
both private and public 
Scanned health 
insurance card 
information at time of 
first visit to the  
diabetes in pregnancy 
clinic   
Will then categorize 
to: 
Private 
Public 
Uninsured 
Nothing on file 
 
 85 
 
insurance were 
considered to have 
private insurance. Persons 
without private or public 
insurance and those with 
only Indian Health Service 
coverage or only a private 
plan that paid for one 
type of service such as 
accidents or dental care 
are considered uninsured 
(CDC, 2012) 
Employment Work for another in 
return for financial or 
other compensation. 
Self-reported 
employment status 
according to the EHR 
choices of yes, or no. 
Fulltime 
Part-time 
Self-employed 
Not employed 
BMI Measure of body fat 
based on height and 
weight in the adult 
male/female  
Weight in kilograms 
divided by the square of 
height in meters (CDC). 
This is a calculation in 
the EHR based on data 
entered for weight and 
height. 
1-100 
Type of GDM Blood sugars are 
maintained through diet 
alone or in combination 
with insulin 
Documentation within 
the EHR of diet 
controlled GDM or 
insulin.  If at any point 
the patient was started 
on insulin, code for 
insulin. 
Diet controlled 
Insulin 
 Preg. with GDM Any prior pregnancies 
with a diagnosis of GDM  
Any prior pregnancies  
with a diagnosis of GDM 
as noted within the EHR 
and validated by 
patient’s report. With 
or without live birth. 
Yes 
No 
PWP FEATURES 
Patient/Provider 
messaging 
Exchange secure e-mail 
with their health care 
providers via the 
patient portal 
(HealthIT.gov) 
 
Measured by the 
number of times the 
patient sent a secure 
message to the GDM 
provider (Nurse or 
MFM) in the third 
trimester. 
Whole number  
 
Flowsheets/Blood sugar 
log 
Enter/review blood 
sugar numbers in a 
secure flowsheet via 
Measured by number of 
times the patient enters 
or reviews data in blood 
Whole number 
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the patient portal. 
Patient and provider as 
access to this data. 
sugar log flowsheets 
during the third 
trimester. 
After visit 
summary/instructions 
Summary and/or 
instructions regarding 
the clinic visit for a 
specific date. Sent via 
secure messaging via 
patient portal. 
Measured by the 
number of times the 
patient selects the after 
visit summaries related 
to GDM visits during the 
third trimester. 
Whole number 
Labs Results of any 
diagnostic test that can 
be reviewed via the 
patient portal  
Number of times 
Hemoglobin A1c levels 
and Glucose tolerance 
tests are reviewed via 
patient portal during 
the third trimester of 
pregnancy. 
Whole number 
Appointment reminders A scheduled reminder 
via the patient portal of 
an upcoming 
appointment for the 
patient. 
The number of times 
the appointment 
reminder for GDM visits 
were reviewed by the 
patient during the third 
trimester of pregnancy.  
Whole number 
Medication refills Medication refill 
message sent by patient 
to provider via secure 
messaging. 
Insulin medication refill 
requests sent to GDM 
provider via secure 
messaging during the 
third trimester of 
pregnancy. 
Whole number 
OUTCOME 
Target blood sugars Percentage of blood 
sugars that are within 
the target range for 
adequate glycemic 
control for GDM 
Percentage of reported 
blood sugars per 
subject that is less than 
125 mg/dL each month 
Percentage per month 
and then for entire 
third trimester 
PWP USE 
PWP frequency of use number of “hits” or 
times the patient 
accesses a feature of 
the PWP. 
 
Number of times a 
subject logs-in or 
accesses a certain 
feature of the PWP 
related to GDM during 
the third trimester 
Whole number 
PWP pattern of use Utilization of features of 
the PWP over time. 
Examples: clustered 
activity to first month 
then stopped using or 
only used one feature 
 PWP features 
accessed  
 number of hits 
to each feature 
 Consistency 
Based on categories of 
users 
List of what features 
used over the study 
period. 
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of the PWP entire time Hit day= any 
day the patient 
accessed the PWP in 
the third trimester 
regardless of the 
number of times 
accessed that day or 
features accessed. 
 Hit month = 
captured any individual 
month where the 
patient accessed any 
feature of the PWP at 
least once.    
 Time of day 
 
 
 
Reported in mean 
 
 
 
 
 
Reported in mean 
 
 
 
 
 
 
Reported in 4 hour 
increments 
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